NVIDIA CORP, 10-K filed on 2/26/2025
Annual Report
v3.25.0.1
Cover Page - USD ($)
shares in Billions, $ in Trillions
12 Months Ended
Jan. 26, 2025
Feb. 21, 2025
Jul. 26, 2024
Cover [Abstract]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Jan. 26, 2025    
Current Fiscal Year End Date --01-26    
Document Transition Report false    
Entity File Number 0-23985    
Entity Registrant Name NVIDIA CORP    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 94-3177549    
Entity Address, Address Line One 2788 San Tomas Expressway    
Entity Address, City or Town Santa Clara    
Entity Address, State or Province CA    
Entity Address, Postal Zip Code 95051    
City Area Code 408    
Local Phone Number 486-2000    
Title of 12(b) Security Common Stock, $0.001 par value per share    
Trading Symbol NVDA    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Document Financial Statement Error Correction [Flag] false    
Entity Shell Company false    
Entity Public Float     $ 2.7
Entity Common Stock, Shares Outstanding   24.4  
Documents Incorporated by Reference
Portions of the registrant's Proxy Statement for its 2025 Annual Meeting of Shareholders to be filed with the Securities and Exchange Commission pursuant to Regulation 14A not later than 120 days after the end of the fiscal year covered by this Annual Report on Form 10-K are incorporated by reference into Part III, Items 10-14 of this Annual Report on Form 10-K.
   
Entity Central Index Key 0001045810    
Document Fiscal Year Focus 2025    
Document Fiscal Period Focus FY    
Amendment Flag false    
v3.25.0.1
Audit Information
12 Months Ended
Jan. 26, 2025
Audit Information [Abstract]  
Auditor Firm ID 238
Auditor Name PricewaterhouseCoopers LLP
Auditor Location San Jose, California
v3.25.0.1
Consolidated Statements of Income - USD ($)
shares in Millions, $ in Millions
12 Months Ended
Jan. 26, 2025
Jan. 28, 2024
Jan. 29, 2023
Income Statement [Abstract]      
Revenue $ 130,497 $ 60,922 $ 26,974
Cost of revenue 32,639 16,621 11,618
Gross profit 97,858 44,301 15,356
Operating expenses      
Research and development 12,914 8,675 7,339
Sales, general and administrative 3,491 2,654 2,440
Acquisition termination cost 0 0 1,353
Total operating expenses 16,405 11,329 11,132
Operating income 81,453 32,972 4,224
Interest income 1,786 866 267
Interest expense (247) (257) (262)
Other, net 1,034 237 (48)
Other income (expense), net 2,573 846 (43)
Income before income tax 84,026 33,818 4,181
Income tax expense (benefit) 11,146 4,058 (187)
Net income $ 72,880 $ 29,760 $ 4,368
Net income per share:      
Basic (in USD per share) $ 2.97 $ 1.21 $ 0.18
Diluted (in USD per share) $ 2.94 $ 1.19 $ 0.17
Weighted average shares used in per share computation:      
Basic (in shares) 24,555 24,690 24,870
Diluted (in shares) 24,804 24,940 25,070
v3.25.0.1
Consolidated Statements of Comprehensive Income - USD ($)
$ in Millions
12 Months Ended
Jan. 26, 2025
Jan. 28, 2024
Jan. 29, 2023
Statement of Comprehensive Income [Abstract]      
Net income $ 72,880 $ 29,760 $ 4,368
Available-for-sale securities:      
Net change in unrealized gain (loss) 1 80 (31)
Reclassification adjustments for net realized gain included in net income 0 0 1
Net change in unrealized gain (loss) 1 80 (30)
Cash flow hedges:      
Net change in unrealized gain 21 38 47
Reclassification adjustments for net realized loss included in net income (21) (48) (49)
Net change in unrealized loss 0 (10) (2)
Other comprehensive income (loss), net of tax 1 70 (32)
Total comprehensive income $ 72,881 $ 29,830 $ 4,336
v3.25.0.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Jan. 26, 2025
Jan. 28, 2024
Current assets:    
Cash and cash equivalents $ 8,589 $ 7,280
Marketable securities 34,621 18,704
Accounts receivable, net 23,065 9,999
Inventories 10,080 5,282
Prepaid expenses and other current assets 3,771 3,080
Total current assets 80,126 44,345
Property and equipment, net 6,283 3,914
Operating lease assets 1,793 1,346
Goodwill 5,188 4,430
Intangible assets, net 807 1,112
Deferred income tax assets 10,979 6,081
Other assets 6,425 4,500
Total assets 111,601 65,728
Current liabilities:    
Accounts payable 6,310 2,699
Accrued and other current liabilities 11,737 6,682
Short-term debt 0 1,250
Total current liabilities 18,047 10,631
Long-term debt 8,463 8,459
Long-term operating lease liabilities 1,519 1,119
Other long-term liabilities 4,245 2,541
Total liabilities 32,274 22,750
Commitments and contingencies - see Note 12 0 0
Shareholders’ equity:    
Preferred stock, $0.001 par value; 20 shares authorized; none issued 0 0
Common stock, $0.001 par value; 80,000 shares authorized; 24,477 shares issued and outstanding as of January 26, 2025; 24,643 shares issued and outstanding as of January 28, 2024 24 25
Additional paid-in capital 11,237 13,109
Accumulated other comprehensive income 28 27
Retained earnings 68,038 29,817
Total shareholders' equity 79,327 42,978
Total liabilities and shareholders' equity $ 111,601 $ 65,728
v3.25.0.1
Consolidated Balance Sheets (Parenthetical) - $ / shares
shares in Millions
Jan. 26, 2025
Jan. 28, 2024
Statement of Financial Position [Abstract]    
Preferred stock, par value (in USD per share) $ 0.001 $ 0.001
Preferred stock, shares authorized (in shares) 20 20
Preferred stock, shares issued (in shares) 0 0
Common stock, par value (in USD per share) $ 0.001 $ 0.001
Common stock, shares authorized (in shares) 80,000 80,000
Common stock, shares issued (in shares) 24,477 24,643
Common stock, shares outstanding (in shares) 24,477 24,643
v3.25.0.1
Consolidated Statements of Shareholders' Equity - USD ($)
shares in Millions, $ in Millions
Total
Common Stock Outstanding
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Beginning balance, common stock outstanding (in shares) at Jan. 30, 2022   25,064      
Beginning balances, shareholders' equity at Jan. 30, 2022 $ 26,612 $ 26 $ 10,362 $ (11) $ 16,235
Increase (Decrease) in Shareholders' Equity          
Net income 4,368       4,368
Other comprehensive (loss) income (32)     (32)  
Issuance of common stock from stock plans (in shares)   312      
Issuance of common stock from stock plans 355   355    
Tax withholding related to vesting of restricted stock units (in shares)   (82)      
Tax withholding related to vesting of restricted stock units (1,475)   (1,475)    
Share repurchased (in shares)   (633)      
Shares repurchased (10,039) $ (1) (4)   (10,034)
Cash dividends declared and paid (398)       (398)
Stock-based compensation 2,710   2,710    
Ending balance, common stock outstanding (in shares) at Jan. 29, 2023   24,661      
Ending balances, shareholders' equity at Jan. 29, 2023 22,101 $ 25 11,948 (43) 10,171
Increase (Decrease) in Shareholders' Equity          
Net income 29,760       29,760
Other comprehensive (loss) income 70     70  
Issuance of common stock from stock plans (in shares)   265      
Issuance of common stock from stock plans 403   403    
Tax withholding related to vesting of restricted stock units (in shares)   (72)      
Tax withholding related to vesting of restricted stock units $ (2,783)   (2,783)    
Share repurchased (in shares) (210) (211)      
Shares repurchased $ (9,746)   (27)   (9,719)
Cash dividends declared and paid (395)       (395)
Stock-based compensation $ 3,568   3,568    
Ending balance, common stock outstanding (in shares) at Jan. 28, 2024 24,643 24,643      
Ending balances, shareholders' equity at Jan. 28, 2024 $ 42,978 $ 25 13,109 27 29,817
Increase (Decrease) in Shareholders' Equity          
Net income 72,880       72,880
Other comprehensive (loss) income 1     1  
Issuance of common stock from stock plans (in shares)   203      
Issuance of common stock from stock plans 490   490    
Tax withholding related to vesting of restricted stock units (in shares)   (59)      
Tax withholding related to vesting of restricted stock units $ (6,930)   (6,930)    
Share repurchased (in shares) (310) (310)      
Shares repurchased $ (34,015) $ (1) (189)   (33,825)
Cash dividends declared and paid (834)       (834)
Stock-based compensation $ 4,757   4,757    
Ending balance, common stock outstanding (in shares) at Jan. 26, 2025 24,477 24,477      
Ending balances, shareholders' equity at Jan. 26, 2025 $ 79,327 $ 24 $ 11,237 $ 28 $ 68,038
v3.25.0.1
Consolidated Statements of Shareholders' Equity (Parenthetical) - $ / shares
12 Months Ended
Jan. 26, 2025
Jan. 28, 2024
Jan. 29, 2023
Statement of Stockholders' Equity [Abstract]      
Cash dividends declared and paid (USD per common share) $ 0.034 $ 0.016 $ 0.016
v3.25.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
12 Months Ended
Jan. 26, 2025
Jan. 28, 2024
Jan. 29, 2023
Cash flows from operating activities:      
Net income $ 72,880 $ 29,760 $ 4,368
Adjustments to reconcile net income to net cash provided by operating activities:      
Stock-based compensation expense 4,737 3,549 2,709
Depreciation and amortization 1,864 1,508 1,544
Deferred income taxes (4,477) (2,489) (2,164)
(Gains) losses on non-marketable equity securities and publicly-held equity securities, net (1,030) (238) 45
Acquisition termination cost 0 0 1,353
Other (502) (278) (7)
Changes in operating assets and liabilities, net of acquisitions:      
Accounts receivable (13,063) (6,172) 822
Inventories (4,781) (98) (2,554)
Prepaid expenses and other assets (395) (1,522) (1,517)
Accounts payable 3,357 1,531 (551)
Accrued and other current liabilities 4,278 2,025 1,341
Other long-term liabilities 1,221 514 252
Net cash provided by operating activities 64,089 28,090 5,641
Cash flows from investing activities:      
Proceeds from maturities of marketable securities 11,195 9,732 19,425
Proceeds from sales of marketable securities 495 50 1,806
Proceeds from sales of non-marketable equity securities 171 1 8
Purchases of marketable securities (26,575) (18,211) (11,897)
Purchases related to property and equipment and intangible assets (3,236) (1,069) (1,833)
Purchases of non-marketable equity securities (1,486) (862) (85)
Acquisitions, net of cash acquired (1,007) (83) (49)
Other 22 (124) 0
Net cash provided by (used in) investing activities (20,421) (10,566) 7,375
Cash flows from financing activities:      
Proceeds related to employee stock plans 490 403 355
Payments related to repurchases of common stock (33,706) (9,533) (10,039)
Payments related to tax on restricted stock units (6,930) (2,783) (1,475)
Repayment of debt (1,250) (1,250) 0
Dividends paid (834) (395) (398)
Principal payments on property and equipment and intangible assets (129) (74) (58)
Other 0 (1) (2)
Net cash used in financing activities (42,359) (13,633) (11,617)
Change in cash and cash equivalents 1,309 3,891 1,399
Cash and cash equivalents at beginning of period 7,280 3,389 1,990
Cash and cash equivalents at end of period 8,589 7,280 3,389
Supplemental disclosures of cash flow information:      
Cash paid for income taxes, net 15,118 6,549 1,404
Cash paid for interest $ 246 $ 252 $ 254
v3.25.0.1
Organization and Summary of Significant Accounting Policies
12 Months Ended
Jan. 26, 2025
Accounting Policies [Abstract]  
Organization and Summary of Significant Accounting Policies Organization and Summary of Significant Accounting Policies
Our Company
Headquartered in Santa Clara, California, NVIDIA was incorporated in California in April 1993 and reincorporated in Delaware in April 1998.
All references to “NVIDIA,” “we,” “us,” “our” or the “Company” mean NVIDIA Corporation and its subsidiaries.
Certain prior fiscal year balances have been reclassified to conform to the current fiscal year presentation.
In June 2024, we executed a ten-for-one stock split of our common stock. All share, equity award, and per share amounts and related shareholders' equity balances presented herein have been retroactively adjusted to reflect the Stock Split.
Fiscal Year
We operate on a 52- or 53-week year, ending on the last Sunday in January. Fiscal years 2025, 2024 and 2023 were all 52-week years.
Principles of Consolidation
Our consolidated financial statements include the accounts of NVIDIA Corporation and our wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from our estimates. On an on-going basis, we evaluate our estimates, including those related to accounts receivable, cash equivalents and marketable securities, goodwill, income taxes, inventories and product purchase commitments, investigation and settlement costs, litigation, non-marketable equity securities, other contingencies, property, plant, and equipment, restructuring and other charges, revenue recognition, and stock-based compensation. These estimates are based on historical facts and various other assumptions that we believe are reasonable.
Revenue Recognition
We derive our revenue from product sales, including hardware and systems, license and development arrangements, software licensing, and cloud services. We determine revenue recognition through the following steps: (1) identification of the contract with a customer; (2) identification of the performance obligations in the contract; (3) determination of the transaction price; (4) allocation of the transaction price to the performance obligations in the contract (where revenue is allocated on a relative standalone selling price basis by maximizing the use of observable inputs to determine the standalone selling price for each performance obligation); and (5) recognition of revenue when, or as, we satisfy a performance obligation. Payment from customers, per our standard payment terms, is generally due shortly after delivery of products, availability of software licenses or commencement of services.
Product Sales Revenue
Revenue from product sales is recognized upon transfer of control of products to customers in an amount that reflects the consideration we expect to receive in exchange for those products. Certain products are sold with support or an extended warranty for the incorporated system, hardware, and/or software. Support and extended warranty revenue are recognized ratably over the service period, or as services are performed. Revenue is recognized net of allowances for returns, customer programs and any taxes collected from customers.
For products sold with a right of return, we record a reduction to revenue by establishing a sales return allowance for estimated product returns at the time revenue is recognized, based primarily on historical return rates. However, if product returns for a fiscal period are anticipated to exceed historical return rates, we may determine that additional sales return allowances are required to accurately reflect our estimated exposure for product returns.
Our customer programs involve rebates, which are designed to serve as sales incentives to resellers of our products in various target markets, and MDFs which represent monies paid to our partners that are earmarked for market segment development and are designed to support our partners’ activities while also promoting NVIDIA products. We account for customer programs as a reduction to revenue and accrue for such programs for potential rebates and MDFs based on the amount we expect to be claimed by customers.
License and Development Arrangements
Our license and development arrangements with customers typically require significant customization of our IP components. As a result, we recognize the revenue from the license and the revenue from the development services as a single performance obligation over the period in which the development services are performed. We measure progress to completion based on actual cost incurred to date as a percentage of the estimated total cost required to complete each project. If a loss on an arrangement becomes probable during a period, we record a provision for such loss in that period.
Software Licensing
Our software licenses provide our customers with a right to use the software when it is made available to the customer. Customers may purchase either perpetual licenses or subscriptions to licenses, which differ mainly in the duration over which the customer benefits from the software. Software licenses are frequently sold along with support, which includes the right to receive, on a when-and-if available basis, future unspecified software updates and upgrades. Revenue from software licenses is recognized up front when the software is made available to the customer. Software support revenue is recognized ratably over the service period, or as services are performed.
Cloud Services
Cloud services, which allow customers to use hosted software and hardware infrastructure without taking possession of the software or hardware, are provided on a subscription basis or a combination of subscription plus usage. Revenue related to subscription-based cloud services is recognized ratably over the contract period. Revenue related to cloud services based on usage is recognized as usage occurs. Cloud services are typically sold on a standalone basis, but certain offerings may be sold with hardware and/or software and related support.
Contracts with Multiple Performance Obligations
Our contracts may contain more than one of the products and services listed above, each of which is separately accounted for as a distinct performance obligation. We account for multiple agreements with a single customer as a single contract if the contractual terms and/or substance of those agreements indicate that they may be so closely related that they are, in effect, parts of a single contract.
We allocate the total transaction price to each distinct performance obligation in an arrangement with multiple performance obligations on a relative standalone selling price basis. The standalone selling price reflects the price we would charge for a specific product or service if it were sold separately in similar circumstances and to similar customers. When determining standalone selling price, we maximize the use of observable inputs.
Product Warranties
We offer a limited warranty to end-users ranging from one to three years for products to repair or replace products for manufacturing defects or hardware component failures. Cost of revenue includes the estimated cost of product warranties that are calculated at the point of revenue recognition. Under limited circumstances, we may offer an extended limited warranty to customers for certain products. We also accrue for known warranty and indemnification issues if a loss is probable and can be reasonably estimated.
Stock-based Compensation
We use the closing trading price of our common stock on the date of grant, minus a dividend yield discount, as the fair value of awards of restricted stock units, or RSUs, and performance stock units, or PSUs, that are based on our corporate financial performance targets. We use a Monte Carlo simulation on the date of grant to estimate the fair value of PSUs that are based on our stock performance compared to market performance, or market-based PSUs. The compensation expense for RSUs and market-based PSUs is recognized using a straight-line attribution method over the requisite employee service period while compensation expense for PSUs is recognized using an accelerated amortization model based on performance targets probable of achievement. We estimate the fair value of shares to be issued under our employee stock purchase plan, or ESPP, using the Black-Scholes model at the commencement of an offering period in March and September of each year. Stock-based compensation for our ESPP is expensed using an accelerated amortization model. Additionally, for RSUs, PSUs, and market-based PSUs, we estimate expected forfeitures based on our historical forfeitures.
Litigation, Investigation and Settlement Costs
We currently, are, and will likely continue to be subject to claims, litigation, and other actions, including potential regulatory proceedings, involving patent and other intellectual property matters, taxes, labor and employment, competition and antitrust, commercial disputes, goods and services offered by us and by third parties, and other matters. There are many uncertainties associated with any litigation or investigation, and we cannot be certain that these actions or other third-party claims against us will be resolved without litigation, fines and/or substantial settlement payments or judgments. If information becomes available that causes us to determine that a loss in any of our pending litigation,
investigations or settlements is probable, and we can reasonably estimate the loss associated with such events, we will record the loss. However, the actual liability in any such litigation or investigation may be materially different from our estimates, which could require us to record additional costs. If we determine that a loss is reasonably possible and the loss or range of loss can be estimated, we disclose the reasonably possible loss.
Foreign Currency Remeasurement
We use the U.S. dollar as our functional currency for our subsidiaries. Foreign currency monetary assets and liabilities are remeasured into United States dollars at end-of-period exchange rates. Non-monetary assets and liabilities such as property and equipment and equity are remeasured at historical exchange rates. Revenue and expenses are remeasured at exchange rates in effect during each period, except for those expenses related to non-monetary balance sheet amounts, which are remeasured at historical exchange rates. Gains or losses from foreign currency remeasurement are included in earnings in our Consolidated Statements of Income and to date have not been significant.
Income Taxes
We recognize federal, state and foreign current tax liabilities or assets based on our estimate of taxes payable or refundable in the current fiscal year by tax jurisdiction. We recognize federal, state and foreign deferred tax assets or liabilities, as appropriate, for our estimate of future tax effects attributable to temporary differences and carryforwards; and we record a valuation allowance to reduce any deferred tax assets by the amount of any tax benefits that, based on available evidence and judgment, are not expected to be realized.
Our calculation of deferred tax assets and liabilities is based on certain estimates and judgments and involves dealing with uncertainties in the application of complex tax laws. Our estimates of deferred tax assets and liabilities may change based, in part, on added certainty or finality to an anticipated outcome, changes in accounting standards or tax laws in the U.S., or foreign jurisdictions where we operate, or changes in other facts or circumstances. In addition, we recognize liabilities for potential U.S. and foreign income tax contingencies based on our estimate of whether, and the extent to which, additional taxes may be due. If we determine that payment of these amounts is unnecessary or if the recorded tax liability is less than our current assessment, we may be required to recognize an income tax benefit or additional income tax expense in our financial statements accordingly.
As of January 26, 2025, we had a valuation allowance of $1.6 billion related to capital loss carryforwards, and certain state and other deferred tax assets that management determined are not likely to be realized due, in part, to jurisdictional projections of future taxable income, including capital gains. To the extent realization of the deferred tax assets becomes more-likely-than-not, we would recognize such deferred tax assets as income tax benefits during the period.
We recognize the benefit from a tax position only if it is more-likely-than-not that the position would be sustained upon audit based solely on the technical merits of the tax position. Our policy is to include interest and penalties related to unrecognized tax benefits as a component of income tax expense.
Net Income Per Share
Basic net income per share is computed using the weighted average number of common shares outstanding during the period. Diluted net income per share is computed using the weighted average number of common and potentially dilutive shares outstanding during the period, using the treasury stock method. Any anti-dilutive effect of equity awards outstanding is not included in the computation of diluted net income per share.
Cash and Cash Equivalents and Marketable Securities
We consider all highly liquid investments that are readily convertible into cash and have an original maturity of three months or less at the time of purchase to be cash equivalents. Marketable securities consist of highly liquid debt investments with maturities of greater than three months when purchased and publicly-held equity securities. We classify these investments as current based on the nature of the investments and their availability for use in current operations.
We classify our cash equivalents and marketable debt securities at the date of acquisition as available-for-sale. These available-for-sale debt securities are reported at fair value with the related unrealized gains and losses included in accumulated other comprehensive income or loss, a component of shareholders’ equity, net of tax. The fair value of interest-bearing debt securities includes accrued interest. Realized gains and losses on the sale of marketable securities are determined using the specific-identification method and recorded in the Other income (expense), net, section of our Consolidated Statements of Income.
Available-for-sale debt securities are subject to impairment review. If the estimated fair value of available-for-sale debt securities is less than its amortized cost basis, we determine if the difference, if any, is caused by expected credit losses and write-down the amortized cost basis of the securities if it is more likely than not we will be required or we intend to
sell the securities before recovery of its amortized cost basis. Allowances for credit losses and write-downs are recognized in the Other income (expense), net section of our Consolidated Statements of Income.
Publicly-held equity securities have readily determinable fair values with changes in fair value recorded in Other income (expense), net.
Fair Value of Financial Instruments
The carrying value of cash equivalents, accounts receivable, accounts payable and accrued liabilities approximate their fair values due to their relatively short maturities as of January 26, 2025 and January 28, 2024. Marketable debt and equity securities are reported at fair value based on quoted market prices. Derivative instruments are recognized as either assets or liabilities and are measured at fair value. The accounting for changes in the fair value of a derivative depends on the intended use of the derivative and the resulting designation. For fair value hedges, the gains or losses are recognized in earnings in the periods of change together with the offsetting losses or gains on the hedged items attributed to the risk being hedged. For derivative instruments designated as accounting hedges, the effective portion of the gains or losses on the derivatives is initially reported as a component of other comprehensive income or loss and is subsequently recognized in earnings when the hedged exposure is recognized in earnings. For derivative instruments not designated as accounting hedges, changes in fair value are recognized in earnings.
Concentration of Credit Risk
Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash equivalents, marketable securities, and accounts receivable. Our investment policy requires the purchase of highly-rated fixed income securities, the diversification of investment type and credit exposures, and includes certain limits on our portfolio maturities. We perform ongoing credit evaluations of our customers’ financial condition and maintain an allowance for potential credit losses. This allowance consists of an amount identified for specific customers and an amount based on overall estimated exposure. Our overall estimated exposure excludes amounts covered by credit insurance and letters of credit.
Inventories
Inventory cost is computed on an adjusted standard basis, which approximates actual cost on an average or first-in, first-out basis. Inventory costs consist primarily of the cost of semiconductors, including wafer fabrication, assembly, testing and packaging, manufacturing support costs, including labor and overhead associated with such purchases, final test yield fallout, and shipping costs, as well as the cost of purchased memory products and other component parts. We charge cost of sales for inventory provisions to write-down our inventory to the lower of cost or net realizable value or for obsolete or excess inventory, and for excess product purchase commitments. Most of our inventory provisions relate to excess quantities of products, based on our inventory levels and future product purchase commitments compared to assumptions about future demand and market conditions. Once inventory has been written-off or written-down, it creates a new cost basis for the inventory that is not subsequently written-up. We record a liability for noncancelable purchase commitments with suppliers for quantities in excess of our future demand forecasts consistent with our valuation of obsolete or excess inventory.
Property and Equipment
Property and equipment are stated at cost less accumulated depreciation. Depreciation of property and equipment is computed using the straight-line method based on the estimated useful lives of the assets of two to seven years. Once an asset is identified for retirement or disposition, the related cost and accumulated depreciation or amortization are removed, and a gain or loss is recorded. The estimated useful lives of our buildings are up to thirty years. Depreciation expense includes the amortization of assets recorded under finance leases. Leasehold improvements and assets recorded under finance leases are amortized over the shorter of the expected lease term or the estimated useful life of the asset.
Leases
We determine if an arrangement is or contains a lease at inception. Operating leases with lease terms of more than 12 months are included in operating lease assets, accrued and other current liabilities, and long-term operating lease liabilities on our consolidated balance sheet. Operating lease assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments over the lease term.
Operating lease assets and liabilities are recognized based on the present value of the remaining lease payments discounted using our incremental borrowing rate. Operating lease assets also include initial direct costs incurred and prepaid lease payments, minus any lease incentives. Our lease terms include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense is recognized on a straight-line basis over the lease term.
Goodwill
Goodwill is subject to our annual impairment test during the fourth quarter of our fiscal year, or earlier if indicators of potential impairment exist. In completing our impairment test, we perform either a qualitative or a quantitative analysis on a reporting unit basis.
Qualitative factors include industry and market considerations, overall financial performance, and other relevant events and factors affecting the reporting units.
The quantitative impairment test considers both the income approach and the market approach to estimate a reporting unit’s fair value. The income and market valuation approaches consider factors that include, but are not limited to, prospective financial information, growth rates, residual values, discount rates and comparable multiples from publicly traded companies in our industry and require us to make certain assumptions and estimates regarding industry economic factors and the future profitability of our business.
Intangible Assets and Other Long-Lived Assets
Intangible assets primarily represent acquired intangible assets including developed technology and customer relationships, as well as rights acquired under technology licenses, patents, and acquired IP. We currently amortize our intangible assets with finite lives over periods ranging from one to twenty years using a method that reflects the pattern in which the economic benefits of the intangible asset are consumed or otherwise used up or, if that pattern cannot be reliably determined, using a straight-line amortization method.
Long-lived assets, such as property and equipment and intangible assets subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable. The recoverability of assets or asset groups to be held and used is measured by a comparison of the carrying amount of an asset or asset group to estimated undiscounted future cash flows expected to be generated by the asset or asset group. If the carrying amount of an asset or asset group exceeds its estimated future cash flows, an impairment charge is recognized for the amount by which the carrying amount of the asset or asset group exceeds the estimated fair value of the asset or asset group. Fair value is determined based on the estimated discounted future cash flows expected to be generated by the asset or asset group. Assets and liabilities to be disposed of would be separately presented in the Consolidated Balance Sheet and the assets would be reported at the lower of the carrying amount or fair value less costs to sell, and would no longer be depreciated.
Business Combination
We allocate the fair value of the purchase price of an acquisition to the tangible assets acquired, liabilities assumed, and intangible assets acquired, based on their estimated fair values. The excess of the fair value of the purchase price over the fair values of these net tangible and intangible assets acquired is recorded as goodwill. Management’s estimates of fair value are based upon assumptions believed to be reasonable, but our estimates and assumptions are inherently uncertain and subject to refinement. The estimates and assumptions used in valuing intangible assets include, but are not limited to, the amount and timing of projected future cash flows, discount rate used to determine the present value of these cash flows and asset lives. These estimates are inherently uncertain and, therefore, actual results may differ from the estimates made. As a result, during the measurement period of up to one year from the acquisition date, we may record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the measurement period's conclusion or final determination of the fair value of the purchase price of an acquisition, whichever comes first, any subsequent adjustments are recorded to our Consolidated Statements of Income.
Acquisition-related expenses are recognized separately from the business combination and expensed as incurred.
Non-Marketable Equity Securities
Non-marketable equity securities consist of investments in privately-held companies that do not have a readily determinable fair value. These investments are measured at cost minus impairment, if any, and are adjusted for changes resulting from observable price changes in orderly transactions for an identical or similar investment in the same issuer, or the measurement alternative. Fair value is based upon observable inputs in an inactive market and the valuation requires our judgment due to the absence of market prices and inherent lack of liquidity. All gains and losses on these investments, realized and unrealized, are recognized in other income (expense), net on our Consolidated Statements of Income.
We assess whether an impairment loss has occurred on our investments in non-marketable equity securities, accounted for under the measurement alternative based on quantitative and qualitative factors. If any impairment is identified for non-marketable equity securities, we write down the investment to its fair value and record the corresponding charge through other income (expense), net on our Consolidated Statements of Income.
Recently Issued Accounting Pronouncements
Recently Adopted Accounting Pronouncement
In November 2023, the Financial Accounting Standards Board, or FASB, issued a new accounting standard requiring disclosures of significant expenses in operating segments. We adopted this standard in our fiscal year 2025 annual report. Refer to Note 16 of the Notes to the Consolidated Financial Statements in Part IV, Item 15 of this Annual Report on Form 10-K for further information.
Recent Accounting Pronouncements Not Yet Adopted
In December 2023, the FASB issued a new accounting standard which includes new and updated income tax disclosures, including disaggregation of information in the rate reconciliation and income taxes paid. We expect to adopt this standard in our fiscal year 2026 annual report. We do not expect the adoption of this standard to have a material impact on our Consolidated Financial Statements other than additional disclosures.
In November 2024, the FASB issued a new accounting standard requiring disclosures of certain additional expense information on an annual and interim basis, including, among other items, the amounts of purchases of inventory, employee compensation, depreciation and intangible asset amortization included within each income statement expense caption, as applicable. We expect to adopt this standard in our fiscal year 2028 annual report. We do not expect the adoption of this standard to have a material impact on our Consolidated Financial Statements other than additional disclosures.
v3.25.0.1
Business Combination
12 Months Ended
Jan. 26, 2025
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]  
Business Combination Business Combination
Termination of the Arm Share Purchase Agreement
In February 2022, NVIDIA and SoftBank Group Corp, or SoftBank, announced the termination of the Share Purchase Agreement whereby NVIDIA would have acquired Arm from SoftBank. The parties agreed to terminate it due to significant regulatory challenges preventing the completion of the transaction. We recorded an acquisition termination cost of $1.4 billion in fiscal year 2023 reflecting the write-off of the prepayment provided at signing.
v3.25.0.1
Stock-Based Compensation
12 Months Ended
Jan. 26, 2025
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation Stock-Based Compensation
Stock-based compensation expense is associated with RSUs, PSUs, market-based PSUs, and our ESPP.
Consolidated Statements of Income include stock-based compensation expense, net of amounts capitalized into inventory and subsequently recognized to cost of revenue, as follows:
 Year Ended
Jan 26, 2025Jan 28, 2024Jan 29, 2023
 (In millions)
Cost of revenue$178 $141 $138 
Research and development3,423 2,532 1,892 
Sales, general and administrative1,136 876 680 
Total$4,737 $3,549 $2,710 
Stock-based compensation capitalized in inventories was not significant during fiscal years 2025, 2024, and 2023.
The following is a summary of equity awards granted under our equity incentive plans:
Year Ended
Jan 26, 2025Jan 28, 2024Jan 29, 2023
(In millions, except per share data)
RSUs, PSUs and Market-based PSUs
Awards granted89 140 250 
Estimated total grant-date fair value$7,834 $5,316 $4,505 
Weighted average grant-date fair value per share$87.99 $37.41 $18.37 
ESPP
Shares purchased30 30 30 
Weighted average price per share$17.74 $15.81 $12.25 
Weighted average grant-date fair value per share$8.61 $6.99 $5.19 
As of January 26, 2025, aggregate unearned stock-based compensation expense was $11.6 billion, which is expected to be recognized over a weighted average period of 2.2 years for RSUs, PSUs, and market-based PSUs, and one year for ESPP.
The fair value of shares issued under our ESPP have been estimated with the following assumptions:
 Year Ended
 Jan 26, 2025Jan 28, 2024Jan 29, 2023
(Using the Black-Scholes model)
ESPP
Weighted average expected life (in years)
0.1-2.0
0.1-2.0
0.1-2.0
Risk-free interest rate
3.6%-5.4%
3.9%-5.5%
—%-4.6%
Volatility
31%-75%
31%-67%
43%-72%
Dividend yield
0.03%
0.06%
0.09%
For ESPP shares, the expected term represents the average term from the first day of the offering period to the purchase date. The risk-free interest rate assumption used to value ESPP shares is based upon observed interest rates on Treasury bills appropriate for the expected term. Our expected stock price volatility assumption for ESPP is estimated using historical volatility. For awards granted, we use the dividend yield at grant date. Our RSUs, PSUs, and market-based PSUs are not eligible for cash dividends prior to vesting; therefore, the fair values of RSUs, PSUs, and market-based PSUs are discounted for the dividend yield.
Additionally, for RSUs, PSUs, and market-based PSUs, we estimate expected forfeitures based on our historical forfeitures.
Equity Incentive Program
We grant RSUs, PSUs, market-based PSUs, and stock purchase rights under the following equity incentive plans. In addition, in connection with our acquisitions of various companies, we have assumed certain stock-based awards granted under their stock incentive plans and converted them into our RSUs.
Amended and Restated 2007 Equity Incentive Plan
In 2007, our shareholders approved the NVIDIA Corporation 2007 Equity Incentive Plan, or as most recently amended and restated, the 2007 Plan.
The 2007 Plan authorizes the issuance of incentive stock options, non-statutory stock options, restricted stock, RSUs, stock appreciation rights, performance stock awards, performance cash awards, and other stock-based awards to employees, directors and consultants. Only our employees may receive incentive stock options. We grant RSUs, PSUs and market-based PSUs under the 2007 Plan. As of January 26, 2025, up to 274 million shares of our common stock could be issued pursuant to stock awards granted under the 2007 Plan, and 1.4 billion shares were available for future grants.
Subject to certain exceptions, RSUs vest generally over four years subject to continued service. PSUs vest over four years, subject to continued service and performance conditions. Market-based PSUs vest on the third anniversary of the date of grant subject to market conditions. However, the number of shares subject to both PSUs and market-based PSUs that are eligible to vest is determined by the Compensation Committee based on achievement of pre-determined criteria.
Amended and Restated 2012 Employee Stock Purchase Plan
In 2012, our shareholders approved the NVIDIA Corporation 2012 Employee Stock Purchase Plan, or as most recently amended and restated, the 2012 Plan.
Employees who participate in the 2012 Plan may have up to 15% of their earnings withheld to purchase shares of common stock. Starting in March 2025, employees may have up to 25% of their earnings withheld to purchase shares of common stock. The Board may decrease this percentage at its discretion. Each offering period is about 24 months, divided into four purchase periods of six months. The price of common stock purchased under our 2012 Plan will be equal to 85% of the lower of the fair market value of the common stock on the commencement date of each offering period or the fair market value of the common stock on each purchase date within the offering. As of January 26, 2025, we had 2.2 billion shares reserved for future issuance under the 2012 Plan.
Equity Award Activity
The following is a summary of our equity award transactions under our equity incentive plans: 
RSUs, PSUs and Market-based PSUs Outstanding
 Number of Shares
Weighted Average Grant-Date Fair Value Per Share
(In millions, except per share data)
Balance as of Jan 28, 2024
367 $24.59 
Granted89 $87.99 
Vested(173)$24.89 
Canceled and forfeited(9)$32.10 
Balance as of Jan 26, 2025
274 $44.75 
Vested and expected to vest after Jan 26, 2025
272 $44.59 
As of January 26, 2025 and January 28, 2024, there were 1.4 billion and 1.5 billion shares, respectively, of common stock available for future grants under our equity incentive plans.
The total fair value of RSUs and PSUs, as of their respective vesting dates, during the years ended January 26, 2025, January 28, 2024, and January 29, 2023, was $15.1 billion, $8.2 billion, and $4.3 billion, respectively.
v3.25.0.1
Net Income Per Share
12 Months Ended
Jan. 26, 2025
Earnings Per Share [Abstract]  
Net Income Per Share Net Income Per Share
The following is a reconciliation of the denominator of the basic and diluted net income per share computations for the periods presented:
 Year Ended
 Jan 26, 2025Jan 28, 2024Jan 29, 2023
 (In millions, except per share data)
Numerator:   
Net income$72,880 $29,760 $4,368 
Denominator:
Basic weighted average shares24,555 24,690 24,870 
Dilutive impact of outstanding equity awards249 250 200 
Diluted weighted average shares24,804 24,940 25,070 
Net income per share:
Basic (1)$2.97 $1.21 $0.18 
Diluted (2)$2.94 $1.19 $0.17 
Anti-dilutive equity awards excluded from diluted net income per share
51 150 400 
(1)    Net income divided by basic weighted average shares.
(2)    Net income divided by diluted weighted average shares.
v3.25.0.1
Goodwill
12 Months Ended
Jan. 26, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill Goodwill
As of January 26, 2025, the total carrying amount of goodwill was $5.2 billion, consisting of goodwill balances allocated to our Compute & Networking and Graphics reporting units of $4.8 billion and $370 million, respectively. As of January 28, 2024, the total carrying amount of goodwill was $4.4 billion, consisting of goodwill balances allocated to our Compute & Networking and Graphics reporting units of $4.1 billion and $370 million, respectively. Goodwill increased by $758 million in fiscal year 2025 from acquisitions and was allocated to our Compute & Networking reporting unit. During the fourth quarters of fiscal years 2025, 2024, and 2023, we completed our annual qualitative impairment tests and concluded that goodwill was not impaired.
v3.25.0.1
Amortizable Intangible Assets
12 Months Ended
Jan. 26, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
Amortizable Intangible Assets Amortizable Intangible Assets
The components of our amortizable intangible assets are as follows:
 Jan 26, 2025Jan 28, 2024
 Gross
Carrying
Amount
Accumulated
Amortization
Net 
Carrying
Amount
Gross
Carrying
Amount
Accumulated
Amortization
Net 
Carrying
Amount
 (In millions)
Acquisition-related intangible assets$2,900 $(2,264)$636 $2,642 $(1,720)$922 
Patents and licensed technology449 (278)171 449 (259)190 
Total intangible assets$3,349 $(2,542)$807 $3,091 $(1,979)$1,112 
Amortization expense associated with intangible assets for fiscal years 2025, 2024, and 2023 was $593 million, $614 million, and $699 million, respectively.
The following table outlines the estimated future amortization expense related to the net carrying amount of intangible assets as of January 26, 2025:
Future Amortization Expense
 (In millions)
Fiscal Year: 
2026$354 
2027236 
202884 
202931 
203010 
2031 and thereafter92 
Total$807 
v3.25.0.1
Cash Equivalents and Marketable Securities
12 Months Ended
Jan. 26, 2025
Investments, Debt and Equity Securities [Abstract]  
Cash Equivalents and Marketable Securities Cash Equivalents and Marketable Securities
The following is a summary of cash equivalents and marketable securities:
 Jan 26, 2025
Amortized
Cost
Unrealized
Gain
Unrealized
Loss
Estimated
Fair Value
Reported as
 Cash EquivalentsMarketable Securities
 (In millions)
Corporate debt securities$18,504 $51 $(29)$18,526 $2,071 $16,455 
Debt securities issued by the U.S. Treasury16,749 42 (22)16,769 1,801 14,968 
Money market funds3,760 — — 3,760 3,760 — 
Debt securities issued by U.S. government agencies2,775 (5)2,777 — 2,777 
Foreign government bonds177 — — 177 137 40 
Certificates of deposit97 — — 97 97 — 
Total debt securities with fair value adjustments recorded in other comprehensive income42,062 100 (56)42,106 7,866 34,240 
Publicly-held equity securities (1)381 — 381 
Total$42,062 $100 $(56)$42,487 $7,866 $34,621 
(1)    Fair value adjustments on publicly-held equity securities are recorded in net income. Beginning in the second quarter of fiscal year 2025, publicly-held equity securities from investments in non-affiliated entities included in other assets (long term) were classified in marketable securities on our Consolidated Balance Sheets.
Net unrealized gains on investments in publicly-held equity securities held at period end were $163 million for fiscal year 2025. Net unrealized gains on investments in publicly-held equity securities held at period end were not significant for fiscal years 2024 and 2023.
Net realized gains on investments in publicly-held equity securities sold were $88 million for fiscal year 2025, reflecting the difference between the sale proceeds and the carrying value of the equity securities at the beginning of the period or the purchase date, if later. Realized gains and losses on investments in publicly-held equity securities sold during fiscal years 2024 and 2023 were not significant.
 Jan 28, 2024
Amortized
Cost
Unrealized
Gain
Unrealized
Loss
Estimated
Fair Value
Reported as
 Cash EquivalentsMarketable Securities
 (In millions)
Corporate debt securities$10,126 $31 $(5)$10,152 $2,231 $7,921 
Debt securities issued by the U.S. Treasury9,517 17 (10)9,524 1,315 8,209 
Money market funds3,031 — — 3,031 3,031 — 
Debt securities issued by U.S. government agencies2,326 (1)2,333 89 2,244 
Certificates of deposit510 — — 510 294 216 
Foreign government bonds174 — — 174 60 114 
Total debt securities with fair value changes recorded in other comprehensive income$25,684 $56 $(16)$25,724 $7,020 $18,704 
The following tables provide the breakdown of unrealized losses, aggregated by investment category and length of time that individual debt securities have been in a continuous loss position:
Jan 26, 2025
 Less than 12 Months12 Months or GreaterTotal
 Estimated Fair ValueGross Unrealized LossEstimated Fair ValueGross Unrealized LossEstimated Fair ValueGross Unrealized Loss
 (In millions)
Debt securities issued by the U.S. Treasury$6,315 $(22)$177 $— $6,492 $(22)
Corporate debt securities5,291 (29)15 — 5,306 (29)
Debt securities issued by U.S. government agencies816 (5)21 — 837 (5)
Total$12,422 $(56)$213 $— $12,635 $(56)
Jan 28, 2024
 Less than 12 Months12 Months or GreaterTotal
 Estimated Fair ValueGross Unrealized LossEstimated Fair ValueGross Unrealized LossEstimated Fair ValueGross Unrealized Loss
 (In millions)
Debt securities issued by the U.S. Treasury$3,343 $(5)$1,078 $(5)$4,421 $(10)
Corporate debt securities1,306 (3)618 (2)1,924 (5)
Debt securities issued by U.S. government agencies670 (1)— — 670 (1)
Total$5,319 $(9)$1,696 $(7)$7,015 $(16)
Gross unrealized losses are related to fixed income securities, driven primarily by changes in interest rates.
The amortized cost and estimated fair value of debt securities included in cash equivalents and marketable securities are shown below by contractual maturity.
 Jan 26, 2025Jan 28, 2024
 Amortized
Cost
Estimated
Fair Value
Amortized
Cost
Estimated
Fair Value
 (In millions)
Less than one year$18,426 $18,450 $16,336 $16,329 
Due in 1 - 5 years23,636 23,656 9,348 9,395 
Total$42,062 $42,106 $25,684 $25,724 
v3.25.0.1
Fair Value of Financial Assets and Liabilities and Non-marketable Equity Securities
12 Months Ended
Jan. 26, 2025
Fair Value Disclosures [Abstract]  
Fair Value of Financial Assets and Liabilities and Non-marketable Equity Securities Fair Value of Financial Assets and Liabilities and Non-marketable Equity Securities
The fair values of our financial assets and liabilities are determined using quoted market prices of identical assets or market prices of similar assets from active markets. We review fair value classification on a quarterly basis.
Fair Value at
Pricing CategoryJan 26, 2025Jan 28, 2024
(In millions)
Assets
Cash equivalents and marketable securities:
Money market fundsLevel 1$3,760 $3,031 
Publicly-held equity securitiesLevel 1$381 $— 
Corporate debt securitiesLevel 2$18,526 $10,152 
Debt securities issued by the U.S. TreasuryLevel 2$16,769 $9,524 
Debt securities issued by U.S. government agenciesLevel 2$2,777 $2,333 
Foreign government bondsLevel 2$177 $174 
Certificates of depositLevel 2$97 $510 
Other assets:
Publicly-held equity securitiesLevel 1$— $225 
Liabilities (1)
0.584% Notes Due 2024
Level 2$— $1,228 
3.20% Notes Due 2026
Level 2$982 $970 
1.55% Notes Due 2028
Level 2$1,136 $1,115 
2.85% Notes Due 2030
Level 2$1,376 $1,367 
2.00% Notes Due 2031
Level 2$1,064 $1,057 
3.50% Notes Due 2040
Level 2$824 $851 
3.50% Notes Due 2050
Level 2$1,482 $1,604 
3.70% Notes Due 2060
Level 2$367 $403 
(1)    Liabilities are carried on our Consolidated Balance Sheets at their original issuance value, net of unamortized debt discount and issuance costs.
Non-marketable Equity Securities
Our non-marketable equity securities are recorded in long-term other assets on our Consolidated Balance Sheets and valued under the measurement alternative. Gains and losses on these investments, realized and unrealized, are recognized in Other income (expense), net on our Consolidated Statements of Income.
Adjustments to the carrying value of our non-marketable equity securities during fiscal years 2025 and 2024 were as follows:
Year Ended
Jan 26, 2025Jan 28, 2024
(In millions)
Balance at beginning of period$1,321 $288 
Adjustments related to non-marketable equity securities:
Net additions1,309 859 
Unrealized gains816 194 
Impairments and unrealized losses(59)(20)
Balance at end of period$3,387 $1,321 
Non-marketable equity securities had cumulative gross unrealized gains of $1.1 billion and $270 million, and cumulative gross unrealized losses and impairments of $105 million and $45 million on securities held as of January 26, 2025 and January 28, 2024, respectively.
In the fourth quarter of fiscal year 2025, one of our private company investments completed a secondary equity transaction that resulted in an unrealized gain of $565 million.
v3.25.0.1
Balance Sheet Components
12 Months Ended
Jan. 26, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Balance Sheet Components Balance Sheet Components
We refer to customers who purchase products directly from NVIDIA as direct customers, such as AIBs, distributors, ODMs, OEMs, and system integrators. We have certain customers that may purchase products directly from NVIDIA and may use either internal resources or third-party system integrators to complete their build. Two direct customers accounted for 17% and 16% of our accounts receivable balance as of January 26, 2025. Two direct customers accounted for 24% and 11% of our accounts receivable balance as of January 28, 2024.
Certain balance sheet components are as follows:
 Jan 26, 2025Jan 28, 2024
Inventories:(In millions)
Raw materials$3,408 $1,719 
Work in process3,399 1,505 
Finished goods3,273 2,058 
Total inventories (1)$10,080 $5,282 
(1)    In fiscal years 2025 and 2024, we recorded an inventory provision of $1.6 billion and $774 million, respectively, in cost of revenue.
 Jan 26, 2025Jan 28, 2024Estimated
Useful Life
Property and Equipment:(In millions)(In years)
Land$511 $218 (A)
Buildings, leasehold improvements, and furniture2,076 1,816 (B)
Equipment, compute hardware, and software7,568 5,200 
2-7
Construction in process529 189 (C)
Total property and equipment, gross10,684 7,423  
Accumulated depreciation and amortization(4,401)(3,509) 
Total property and equipment, net$6,283 $3,914  
(A)Land is a non-depreciable asset.
(B)The estimated useful lives of our buildings are up to thirty years. Leasehold improvements and finance leases are amortized based on the lesser of either the asset’s estimated useful life or the expected remaining lease term.
(C)Construction in process represents assets that are not available for their intended use as of the balance sheet date.
Depreciation expense for fiscal years 2025, 2024, and 2023 was $1.3 billion, $894 million, and $844 million, respectively.
Accumulated amortization of leasehold improvements and finance leases was $410 million and $400 million as of January 26, 2025 and January 28, 2024, respectively.
Property, equipment and intangible assets acquired by assuming related liabilities during fiscal years 2025, 2024, and 2023 were $525 million, $170 million, and $374 million, respectively.
 Jan 26, 2025Jan 28, 2024
Other Assets (Long Term):(In millions)
Non-marketable equity securities$3,387 $1,321 
Prepaid supply and capacity agreements (1)1,747 2,458 
Income tax receivable750 — 
Prepaid royalties340 364 
Other201 357 
Total other assets$6,425 $4,500 
(1)Prepaid supply and capacity agreements of $3.3 billion and $2.5 billion were included in Prepaid expenses and other current assets as of January 26, 2025 and January 28, 2024, respectively.
 Jan 26, 2025Jan 28, 2024
Accrued and Other Current Liabilities:(In millions)
Customer program accruals$4,880 $2,081 
Excess inventory purchase obligations (1)2,095 1,655 
Product warranty and return provisions1,373 415 
Taxes payable881 296 
Accrued payroll and related expenses848 675 
Deferred revenue (2)837 764 
Operating leases288 228 
Licenses and royalties175 182 
Unsettled share repurchases132 187 
Other228 199 
Total accrued and other current liabilities$11,737 $6,682 
(1)In fiscal years 2025 and 2024, we recorded an expense of approximately $2.0 billion and $1.4 billion, respectively, in cost of revenue.
(2)Includes customer advances and unearned revenue related to hardware support, software support, cloud services, and license and development arrangements. The balance as of January 26, 2025 and January 28, 2024 included $81 million and $233 million of customer advances, respectively.
 Jan 26, 2025Jan 28, 2024
Other Long-Term Liabilities:(In millions)
Income tax payable (1)$2,188 $1,361 
Deferred revenue (2)976 573 
Deferred income tax886 462 
Licenses payable116 80 
Other79 65 
Total other long-term liabilities$4,245 $2,541 
(1)Income tax payable is comprised of the long-term portion of the one-time transition tax payable, unrecognized tax benefits, and related interest and penalties.
(2)Includes unearned revenue related to hardware support, software support and cloud services.
Deferred Revenue
The following table shows the changes in short- and long-term deferred revenue during fiscal years 2025 and 2024:
 Jan 26, 2025Jan 28, 2024
(In millions)
Balance at beginning of period$1,337 $572 
Deferred revenue additions (1)5,083 2,038 
Revenue recognized (2)(4,607)(1,273)
Balance at end of period$1,813 $1,337 
(1)    Deferred revenue additions includes $3.6 billion and $783 million related to customer advances for fiscal years 2025 and 2024, respectively.
(2)    Revenue recognized includes $3.7 billion and $585 million related to customer advances for fiscal years 2025 and 2024, respectively.
We recognized revenue of $729 million and $338 million in fiscal years 2025 and 2024, respectively, that were included in the prior year end deferred revenue balance.
As of January 26, 2025, revenue related to remaining performance obligations from contracts greater than one year in length was $1.7 billion, which includes $1.6 billion from deferred revenue and $151 million which has not yet been billed nor recognized as revenue. Approximately 39% of revenue from contracts greater than one year in length will be recognized over the next twelve months.
v3.25.0.1
Derivative Financial Instruments
12 Months Ended
Jan. 26, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Financial Instruments Derivative Financial Instruments
We utilize foreign currency forward contracts to mitigate the impact of foreign currency exchange rate movements on our operating expenses. The foreign currency forward contracts for operating expenses are designated as accounting hedges. Gains or losses on the contracts are recorded in accumulated other comprehensive income or loss and reclassified to operating expense when the related operating expenses are recognized in earnings. In fiscal years 2025 and 2024, the impact of foreign currency forward contracts designated as accounting hedges on other comprehensive income or loss was not significant and all such instruments were determined to be highly effective.
We also entered into foreign currency forward contracts mitigating the impact of foreign currency movements on monetary assets and liabilities. For our foreign currency contracts for assets and liabilities, the change in fair value of these non-designated contracts was recorded in other income or expense and offsets the change in fair value of the hedged foreign currency denominated monetary assets and liabilities, which was also recorded in other income or expense.
The table below presents the notional value of our foreign currency contracts outstanding:
Jan 26, 2025Jan 28, 2024
 (In millions)
Designated as accounting hedges$1,424 $1,168 
Not designated as accounting hedges$1,297 $597 
The unrealized gains and losses or fair value of our foreign currency contracts were not significant as of January 26, 2025 and January 28, 2024.
As of January 26, 2025, all foreign currency contracts mature within 18 months. The expected realized gains and losses deferred into accumulated other comprehensive income or loss related to foreign currency forward contracts within the next twelve months were not significant.
v3.25.0.1
Debt
12 Months Ended
Jan. 26, 2025
Debt Disclosure [Abstract]  
Debt Debt
Long-Term Debt
 Expected
Remaining Term (years)
Effective
Interest Rate
Jan 26, 2025Jan 28, 2024
   (In millions)
0.584% Notes Due 2024 (1)
0.66%$— $1,250 
3.20% Notes Due 2026
1.63.31%1,000 1,000 
1.55% Notes Due 2028
3.41.64%1,250 1,250 
2.85% Notes Due 2030
5.22.93%1,500 1,500 
2.00% Notes Due 2031
6.42.09%1,250 1,250 
3.50% Notes Due 2040
15.23.54%1,000 1,000 
3.50% Notes Due 2050
25.23.54%2,000 2,000 
3.70% Notes Due 2060
35.23.73%500 500 
Unamortized debt discount and issuance costs  (37)(41)
Net carrying amount  8,463 9,709 
Less short-term portion— (1,250)
Total long-term portion$8,463 $8,459 
(1)    In fiscal year 2025, we repaid the 0.584% Notes Due 2024.
Our notes are unsecured senior obligations. Existing and future liabilities of our subsidiaries will be effectively senior to the notes. Our notes pay interest semi-annually. We may redeem each of our notes prior to maturity, subject to a make-whole premium. The maturity of the notes is calendar year.
As of January 26, 2025, we complied with the required covenants, which are non-financial in nature, under the outstanding notes.
Commercial Paper
We have a $575 million commercial paper program to support general corporate purposes. As of January 26, 2025, we had no commercial paper outstanding.
v3.25.0.1
Commitments and Contingencies
12 Months Ended
Jan. 26, 2025
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Purchase Obligations
Our purchase obligations reflect our commitment to purchase components used to manufacture our products, including long-term supply and capacity agreements, certain software and technology licenses, other goods and services and long-lived assets.
As of January 26, 2025, we had outstanding inventory purchase and long-term supply and capacity obligations totaling $30.8 billion, an increase from the prior year led by commitments, capacity and components for new product introductions, including our new Blackwell architecture. We enter into agreements with contract manufacturers that allow them to procure inventory based upon our defined criteria, and in certain instances, these agreements are cancellable, able to be rescheduled, or adjustable for our business needs prior to placing firm orders. Though, changes to these agreements may result in additional costs. Other non-inventory purchase obligations were $14.3 billion, including $10.9 billion of multi-year cloud service agreements. We expect our cloud service agreements to primarily be used to support our research and development efforts, as well as our DGX Cloud offerings.
Total future purchase commitments as of January 26, 2025 are as follows:
Commitments
 (In millions)
Fiscal Year: 
2026$35,727 
20273,666 
20282,992 
20292,054 
2030422 
2031 and thereafter218 
Total$45,079 
Accrual for Product Warranty Liabilities
The estimated amount of product warranty liabilities was $1.3 billion and $306 million as of January 26, 2025 and January 28, 2024, respectively. The estimated product returns and product warranty activity consisted of the following:
Year Ended
Jan 26, 2025Jan 28, 2024Jan 29, 2023
(In millions)
Balance at beginning of period$306 $82 $46 
Additions1,203 278 145 
Utilization(219)(54)(109)
Balance at end of period$1,290 $306 $82 
In fiscal years 2025, 2024, and 2023 the additions in product warranty liabilities primarily related to Compute & Networking segment.
We have provided indemnities for matters such as tax, product, and employee liabilities. We have included intellectual property indemnification provisions in our technology-related agreements with third parties. Maximum potential future payments cannot be estimated because many of these agreements do not have a maximum stated liability. We have not recorded any liability in our Consolidated Financial Statements for such indemnifications.
Litigation
Securities Class Action and Derivative Lawsuits
The plaintiffs in the putative securities class action lawsuit, captioned 4:18-cv-07669-HSG, initially filed on December 21, 2018 in the United States District Court for the Northern District of California, and titled In Re NVIDIA Corporation Securities Litigation, filed an amended complaint on May 13, 2020. The amended complaint asserted that NVIDIA and certain NVIDIA executives violated Section 10(b) of the Securities Exchange Act of 1934, as amended, or the Exchange Act, and SEC Rule 10b-5, by making materially false or misleading statements related to channel inventory and the impact of cryptocurrency mining on GPU demand between May 10, 2017 and November 14, 2018. Plaintiffs also alleged that the NVIDIA executives who they named as defendants violated Section 20(a) of the Exchange Act. Plaintiffs sought class certification, an award of unspecified compensatory damages, an award of reasonable costs and expenses, including attorneys’ fees and expert fees, and further relief as the Court may deem just and proper. On March 2, 2021, the district court granted NVIDIA’s motion to dismiss the complaint without leave to amend, entered judgment in favor of NVIDIA and closed the case. On March 30, 2021, plaintiffs filed an appeal from judgment in the United States Court of Appeals for the Ninth Circuit, case number 21-15604. On August 25, 2023, a majority of a three-judge Ninth Circuit panel affirmed in part and reversed in part the district court’s dismissal of the case, with a third judge dissenting on the basis that the district court did not err in dismissing the case. On November 15, 2023, the Ninth Circuit denied NVIDIA’s petition for rehearing en banc of the Ninth Circuit panel’s majority decision to reverse in part the dismissal of the case, which NVIDIA had filed on October 10, 2023. On December 5, 2023, the Ninth Circuit granted NVIDIA’s motion to stay the mandate pending NVIDIA’s petition for a writ of certiorari in the Supreme Court of the United States and the Supreme Court’s final disposition of the matter. NVIDIA filed a petition for a writ of certiorari on March 4, 2024. On June 17, 2024, the Supreme Court of the United States granted NVIDIA’s petition for a writ of certiorari. After briefing and argument, the Supreme
Court dismissed NVIDIA’s writ of certiorari as improvidently granted on December 11, 2024, and issued judgment on January 13, 2025. On February 20, 2025, the Ninth Circuit’s judgment, entered August 25, 2023 and corrected August 28, 2023, took effect, and the case was remanded to the district court for further proceedings.
The putative derivative lawsuit pending in the United States District Court for the Northern District of California, captioned 4:19-cv-00341-HSG, initially filed January 18, 2019 and titled In re NVIDIA Corporation Consolidated Derivative Litigation, was stayed pending resolution of the plaintiffs’ appeal in the In Re NVIDIA Corporation Securities Litigation action. On February 22, 2022, the court administratively closed the case, but stated that it would reopen the case once the appeal in the In Re NVIDIA Corporation Securities Litigation action is resolved. The case has not yet been reopened by the court. The lawsuit asserts claims, purportedly on behalf of us, against certain officers and directors of the Company for breach of fiduciary duty, unjust enrichment, waste of corporate assets, and violations of Sections 14(a), 10(b), and 20(a) of the Exchange Act based on the dissemination of allegedly false and misleading statements related to channel inventory and the impact of cryptocurrency mining on GPU demand. The plaintiffs are seeking unspecified damages and other relief, including reforms and improvements to NVIDIA’s corporate governance and internal procedures.
The putative derivative actions initially filed September 24, 2019 and pending in the United States District Court for the District of Delaware, Lipchitz v. Huang, et al. (Case No. 1:19-cv-01795-MN) and Nelson v. Huang, et. al. (Case No. 1:19-cv-01798-MN), were stayed pending resolution of the plaintiffs’ appeal in the In Re NVIDIA Corporation Securities Litigation action. On February 5, 2025, after the Supreme Court issued its judgment dismissing the Company’s petition for writ of certiorari as improvidently granted in the In Re NVIDIA Corporation Securities Litigation action, the district court extended the stay for 30 days while the parties discuss next steps and ordered the parties to file a joint status report by March 7, 2025. The lawsuits assert claims, purportedly on behalf of us, against certain officers and directors of the Company for breach of fiduciary duty, unjust enrichment, insider trading, misappropriation of information, corporate waste and violations of Sections 14(a), 10(b), and 20(a) of the Exchange Act based on the dissemination of allegedly false, and misleading statements related to channel inventory and the impact of cryptocurrency mining on GPU demand. The plaintiffs seek unspecified damages and other relief, including disgorgement of profits from the sale of NVIDIA stock and unspecified corporate governance measures.
Another putative derivative action was filed on October 30, 2023 in the Court of Chancery of the State of Delaware, captioned Horanic v. Huang, et al. (Case No. 2023-1096-KSJM). This lawsuit asserts claims, purportedly on behalf of us, against certain officers and directors of the Company for breach of fiduciary duty and insider trading based on the dissemination of allegedly false and misleading statements related to channel inventory and the impact of cryptocurrency mining on GPU demand. The plaintiffs seek unspecified damages and other relief, including disgorgement of profits from the sale of NVIDIA stock and reform of unspecified corporate governance measures. This derivative matter is stayed pending the final resolution of In Re NVIDIA Corporation Securities Litigation action.
Accounting for Loss Contingencies
As of January 26, 2025, there are no accrued contingent liabilities associated with the legal proceedings described above based on our belief that liabilities, while reasonably possible, are not probable. Further, any possible loss or range of loss in these matters cannot be reasonably estimated at this time. We are engaged in legal actions not described above arising in the ordinary course of business and, while there can be no assurance of favorable outcomes, we believe that the ultimate outcome of these actions will not have a material adverse effect on our operating results, liquidity or financial position.
v3.25.0.1
Income Taxes
12 Months Ended
Jan. 26, 2025
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
The income tax expense (benefit) applicable to income before income taxes consists of the following:
 Year Ended
 Jan 26, 2025Jan 28, 2024Jan 29, 2023
 (In millions)
Current income taxes:   
Federal$14,032 $5,710 $1,703 
State892 335 46 
Foreign699 502 228 
Total current15,623 6,547 1,977 
Deferred income taxes:
Federal(4,515)(2,499)(2,165)
State(242)(206)— 
Foreign280 216 
Total deferred(4,477)(2,489)(2,164)
Income tax expense (benefit)$11,146 $4,058 $(187)
Income before income tax consists of the following:
 Year Ended
 Jan 26, 2025Jan 28, 2024Jan 29, 2023
 (In millions)
U.S.$77,456 $29,495 $3,477 
Foreign6,570 4,323 704 
Income before income tax$84,026 $33,818 $4,181 
The income tax expense (benefit) differs from the amount computed by applying the U.S. federal statutory rate of 21% to income before income taxes as follows:
 Year Ended
 Jan 26, 2025Jan 28, 2024Jan 29, 2023
 (In millions, except percentages)
Tax expense computed at federal statutory rate$17,645 21.0 %$7,102 21.0 %$878 21.0 %
Expense (benefit) resulting from:
State income taxes, net of federal tax effect554 0.7 %120 0.4 %50 1.2 %
Foreign-derived intangible income(2,976)(3.5)%(1,408)(4.2)%(739)(17.7)%
Stock-based compensation(2,097)(2.5)%(741)(2.2)%(309)(7.4)%
U.S. federal research and development tax credit(990)(1.2)%(431)(1.3)%(278)(6.6)%
Foreign tax rate differential(984)(1.2)%(467)(1.4)%(83)(2.0)%
Acquisition termination cost— — %— — %261 6.2 %
Other(6)— %(117)(0.3)%33 0.8 %
Income tax expense (benefit)$11,146 13.3 %$4,058 12.0 %$(187)(4.5)%
The tax effect of temporary differences that gives rise to significant portions of the deferred tax assets and liabilities are presented below:
 Jan 26, 2025Jan 28, 2024
 (In millions)
Deferred tax assets: 
Capitalized research and development expenditure$6,256 $3,376 
GILTI deferred tax assets2,820 1,576 
Accruals and reserves, not currently deductible for tax purposes2,058 1,121 
Research and other tax credit carryforwards759 936 
Net operating loss and capital loss carryforwards456 439 
Operating lease liabilities299 263 
Stock-based compensation124 106 
Property, equipment and intangible assets82 64 
Other deferred tax assets360 179 
Gross deferred tax assets13,214 8,060 
Less valuation allowance(1,610)(1,552)
Total deferred tax assets11,604 6,508 
Deferred tax liabilities:
Unremitted earnings of foreign subsidiaries(891)(502)
Operating lease assets(286)(255)
Equity investments(264)(60)
Acquired intangibles(70)(74)
Gross deferred tax liabilities(1,511)(891)
Net deferred tax asset (1)$10,093 $5,617 
(1)    Net deferred tax asset includes long-term deferred tax assets of $11 billion and $6.1 billion and long-term deferred tax liabilities of $886 million and $462 million for fiscal years 2025 and 2024, respectively. Long-term deferred tax liabilities are included in other long-term liabilities on our Consolidated Balance Sheets.
As of January 26, 2025, we intend to indefinitely reinvest approximately $1.4 billion of cumulative undistributed earnings held by certain subsidiaries. We have not provided the amount of unrecognized deferred tax liabilities for temporary differences related to these investments as the determination of such amount is not practicable.
As of both January 26, 2025 and January 28, 2024, we had a valuation allowance of $1.6 billion related to capital loss carryforwards, and certain state and other deferred tax assets that management determined are not likely to be realized due, in part, to jurisdictional projections of future taxable income, including capital gains. To the extent realization of the deferred tax assets becomes more-likely-than-not, we would recognize such deferred tax assets as income tax benefits during the period.
Given our current and possible future earnings, we believe that we may release the valuation allowance associated with certain state deferred tax assets in the near term, which would decrease our income tax expense for the period the release is recorded. The timing and amount of the valuation allowance release could vary based on our assessment of all available information.
As of January 26, 2025, we had U.S. federal, state and foreign net operating loss carryforwards of $479 million, $332 million and $349 million, respectively. The federal and state carryforwards will begin to expire in fiscal years 2026 and 2027, respectively. The foreign net operating loss carryforwards of $349 million may be carried forward indefinitely. As of January 26, 2025, we had federal research tax credit carryforwards of $46 million, before the impact of uncertain tax positions, that will begin to expire in fiscal year 2026. We have state research tax credit carryforwards of $1.5 billion, before the impact of uncertain tax positions. $1.4 billion is attributable to the State of California and may be carried over indefinitely and $98 million is attributable to various other states and will begin to expire in fiscal year 2026. As of January 26, 2025, we had federal capital loss carryforwards of $1.3 billion that will begin to expire in fiscal year 2028.
Our tax attributes remain subject to audit and may be adjusted for changes or modification in tax laws, other authoritative interpretations thereof, or other facts and circumstances. Utilization of tax attributes may also be subject to limitations due to ownership changes and other limitations provided by the Internal Revenue Code and similar state and foreign tax provisions. If any such limitations apply, the tax attributes may expire or be denied before utilization.
A reconciliation of gross unrecognized tax benefits is as follows:
 Jan 26, 2025Jan 28, 2024Jan 29, 2023
 (In millions)
Balance at beginning of period$1,670 $1,238 $1,013 
Increases in tax positions for current year1,268 616 268 
Increases in tax positions for prior years48 87 
Decreases in tax positions for prior years(88)(148)(15)
Lapse in statute of limitations(27)(19)(20)
Settlements(10)(104)(9)
Balance at end of period$2,861 $1,670 $1,238 
Included in the balance of unrecognized tax benefits as of January 26, 2025 are $2 billion of tax benefits that would affect our effective tax rate if recognized.
We classify an unrecognized tax benefit as a current liability, or amount refundable, to the extent that we anticipate payment or receipt of cash for income taxes within one year. The amount is classified as a long-term liability, or reduction of long-term amount refundable, if we anticipate payment or receipt of cash for income taxes during a period beyond a year.
We include interest and penalties related to unrecognized tax benefits as a component of income tax expense. We recognized net interest and penalties related to unrecognized tax benefits in the income tax expense line of our consolidated statements of income of $92 million, $42 million, and $33 million during fiscal years 2025, 2024, and 2023, respectively. As of January 26, 2025 and January 28, 2024, we have accrued $251 million and $140 million, respectively, for the payment of interest and penalties related to unrecognized tax benefits, which is not included as a component of our gross unrecognized tax benefits.
While we believe that we have adequately provided for all tax positions, amounts asserted by tax authorities could be greater or less than our accrued position. Accordingly, our provisions on federal, state and foreign tax-related matters to be recorded in the future may change as revised estimates are made or the underlying matters are settled or otherwise resolved. As of January 26, 2025, we have not identified any positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will significantly increase or decrease within the next twelve months.
We are subject to taxation by taxing authorities both in the United States and other countries. As of January 26, 2025, the significant tax jurisdictions that may be subject to examination include the United States for fiscal years after 2021, as well as China, Germany, Hong Kong, India, Israel, Taiwan, and the United Kingdom for fiscal years 2014 through 2024. As of January 26, 2025, the significant tax jurisdictions for which we are currently under examination include Germany, Hong Kong, India, Israel, and Taiwan for fiscal years 2014 through 2024, and the State of California for fiscal years 2020 to 2022.
v3.25.0.1
Shareholders’ Equity
12 Months Ended
Jan. 26, 2025
Equity [Abstract]  
Shareholders’ Equity Shareholders’ Equity
Capital Return Program
On August 26, 2024, our Board of Directors approved an additional $50 billion to our share repurchase authorization, without expiration. In fiscal years 2025 and 2024, we repurchased 310 million and 210 million shares of our common stock for $34.0 billion and $9.7 billion, respectively. As of January 26, 2025, we were authorized, subject to certain specifications, to repurchase up to $38.7 billion of our common stock. Our share repurchase program aims to offset dilution from shares issued to employees while maintaining adequate liquidity to meet our operating requirements. We may pursue additional share repurchases as we weigh market factors and other investment opportunities.
From January 27, 2025 through February 21, 2025, we repurchased 29 million shares for $3.7 billion pursuant to a pre-established trading plan.
In fiscal years 2025, 2024, and 2023, we paid cash dividends to our shareholders of $834 million, $395 million, and $398 million, respectively. The payment of future cash dividends is subject to our Board of Directors' continuing determination that the declaration of dividends is in the best interests of our shareholders.
v3.25.0.1
Employee Retirement Plans
12 Months Ended
Jan. 26, 2025
Retirement Benefits [Abstract]  
Employee Retirement Plans Employee Retirement Plans
We provide tax-qualified defined contribution plans to eligible employees in the U.S. and certain other countries. Our contribution expense for fiscal years 2025, 2024, and 2023 was $314 million, $255 million, and $227 million, respectively.
v3.25.0.1
Segment Information
12 Months Ended
Jan. 26, 2025
Segment Reporting [Abstract]  
Segment Information Segment Information
Our Chief Executive Officer is our chief operating decision maker, or CODM, and reviews financial information presented on an operating segment basis for purposes of making decisions and assessing financial performance. Our CODM assesses operating performance of each segment based on regularly provided segment revenue and segment operating income. Operating results by segment include costs or expenses directly attributable to each segment, and costs or expenses that are leveraged across our unified architecture and therefore allocated between our two segments. Our CODM reviews expenses on a consolidated basis, and expenses attributable to each segment are not regularly provided to our CODM.
The Compute & Networking segment includes our Data Center accelerated computing platforms and AI solutions and software; networking; automotive platforms and autonomous and electric vehicle solutions; Jetson for robotics and other embedded platforms; and DGX Cloud computing services.
The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, and solutions for gaming platforms; Quadro/NVIDIA RTX GPUs for enterprise workstation graphics; vGPU software for cloud-based visual and virtual computing; automotive platforms for infotainment systems; and Omniverse Enterprise software for building and operating industrial AI and digital twin applications.
The “All Other” category includes the expenses that are not allocated to either Compute & Networking or Graphics for purposes of making operating decisions or assessing financial performance. The expenses include stock-based compensation expense, corporate infrastructure and support costs, acquisition-related and other costs, and other non-recurring charges and benefits that our CODM deems to be enterprise in nature.
Our CODM does not review any information regarding total assets on a reportable segment basis. There are no intersegment transactions. The accounting policies for segment reporting are the same as for our consolidated financial statements. The table below presents details of our reportable segments and the “All Other” category.
 Compute & NetworkingGraphicsAll OtherConsolidated
(In millions)
Year Ended Jan 26, 2025
   
Revenue$116,193 $14,304 $— $130,497 
Other segment items (1)33,318 9,219 
Operating income (loss)$82,875 $5,085 $(6,507)$81,453 
Year Ended Jan 28, 2024
   
Revenue$47,405 $13,517 $— $60,922 
Other segment items (1)15,389 7,671 
Operating income (loss)$32,016 $5,846 $(4,890)$32,972 
Year Ended Jan 29, 2023
   
Revenue$15,068 $11,906 $— $26,974 
Other segment items (1)9,985 7,354 
Operating income (loss)$5,083 $4,552 $(5,411)$4,224 
(1)Other segment items for the Compute & Networking and Graphics reportable segments primarily include product costs and inventory provisions, compensation and benefits excluding stock-based compensation expense, compute and infrastructure expenses, and engineering development costs.
Depreciation and amortization expense attributable to our Compute and Networking segment for fiscal years 2025, 2024, and 2023 was $732 million, $457 million, and $377 million, respectively. Depreciation and amortization expense attributable to our Graphics segment for fiscal years 2025, 2024, and 2023 was $372 million, $307 million, and $315 million, respectively. Acquisition-related intangible amortization expense is not allocated to either Compute & Networking or Graphics for purposes of making operating decisions or assessing financial performance and is included in “All Other”.
Year Ended
Jan 26, 2025Jan 28, 2024Jan 29, 2023
Reconciling items included in "All Other" category:(In millions)
Stock-based compensation expense$(4,737)$(3,549)$(2,710)
Unallocated cost of revenue and operating expenses(1,171)(728)(595)
Acquisition-related and other costs(602)(583)(674)
Acquisition termination cost— — (1,353)
Other(30)(79)
Total$(6,507)$(4,890)$(5,411)
Revenue by geographic area is based upon the billing location of the customer. The end customer and shipping location may be different from our customer’s billing location.
 Year Ended
 Jan 26, 2025Jan 28, 2024Jan 29, 2023
Geographic Revenue based upon Customer Billing Location:(In millions)
United States$61,257 $26,966 $8,292 
Singapore (1)23,684 6,831 2,288 
Taiwan20,573 13,405 6,986 
China (including Hong Kong)17,108 10,306 5,785 
Other7,875 3,414 3,623 
Total revenue$130,497 $60,922 $26,974 
(1) Singapore represented 18% of fiscal year 2025 total revenue based upon customer billing location. Customers use Singapore to centralize invoicing while our products are almost always shipped elsewhere. Shipments to Singapore were less than 2% of fiscal year 2025 total revenue.
Revenue from sales to customers outside of the United States accounted for 53%, 56%, and 69% of total revenue for fiscal years 2025, 2024, and 2023, respectively. The increase in revenue to the United States for fiscal years 2025 and 2024 was primarily due to higher U.S.-based Compute & Networking segment demand.
We refer to customers who purchase products directly from NVIDIA as direct customers, such as AIBs, distributors, ODMs, OEMs, and system integrators. We have certain customers that may purchase products directly from NVIDIA and may use either internal resources or third-party system integrators to complete their build. We also have indirect customers, who purchase products through our direct customers; indirect customers include CSPs, consumer internet companies, enterprises, and public sector entities.
Sales to direct customers which represented 10% or more of total revenue, all of which were primarily attributable to the Compute & Networking segment, are presented in the following table:
Year Ended
Jan 26, 2025Jan 28, 2024
Direct Customer A12 %*
Direct Customer B11 %13 %
Direct Customer C11 %*
* Less than 10% of total revenue.
No customer represented 10% or more of total revenue for fiscal year 2023.
The following table summarizes revenue by specialized markets:
 Year Ended
 Jan 26, 2025Jan 28, 2024Jan 29, 2023
Revenue by End Market:(In millions)
Data Center$115,186 $47,525 $15,005 
Compute102,196 38,950 11,317 
Networking12,990 8,575 3,688 
Gaming11,350 10,447 9,067 
Professional Visualization1,878 1,553 1,544 
Automotive1,694 1,091 903 
OEM and Other389 306 455 
Total revenue$130,497 $60,922 $26,974 
The following table presents summarized information for long-lived assets by country. Long-lived assets consist of property and equipment and exclude other assets, operating lease assets, goodwill, and intangible assets.
 Jan 26, 2025Jan 28, 2024
Long-lived assets:(In millions)
United States$3,626 $2,595 
Taiwan1,481 773 
Israel840 325 
Other336 221 
Total long-lived assets$6,283 $3,914 
v3.25.0.1
Leases
12 Months Ended
Jan. 26, 2025
Leases [Abstract]  
Leases Leases
Our lease obligations primarily consist of operating leases for our headquarters' campus and domestic and international offices and data centers, with lease periods expiring between fiscal years 2026 and 2037.
Future minimum lease obligations under our non-cancelable lease agreements as of January 26, 2025 were as follows:
Operating Lease Obligations
 (In millions)
Fiscal Year: 
2026$354 
2027331 
2028337 
2029301 
2030226 
2031 and thereafter537 
Total2,086 
Less imputed interest279 
Present value of net future minimum lease payments1,807 
Less short-term operating lease liabilities288 
Long-term operating lease liabilities$1,519 
Between fiscal years 2026 and 2030, we expect to commence leases with future obligations of $7.6 billion primarily of data center and office operating leases, with lease terms of 3 to 15.5 years.
Operating lease expenses for fiscal years 2025, 2024, and 2023 were $356 million, $269 million, and $193 million, respectively. Short-term and variable lease expenses for fiscal years 2025, 2024, and 2023 were not significant.
Other information related to leases was as follows:
Year Ended
Jan 26, 2025Jan 28, 2024Jan 29, 2023
 (In millions)
Supplemental cash flows information 
Operating cash flow used for operating leases$313 $286 $184 
Operating lease assets obtained in exchange for lease obligations$877 $531 $358 
As of January 26, 2025, our operating leases have a weighted average remaining lease term of 6.5 years and a weighted average discount rate of 4.16%. As of January 28, 2024, our operating leases had a weighted average remaining lease term of 6.1 years and a weighted average discount rate of 3.76%.
v3.25.0.1
Schedule II - Valuation and Qualifying Accounts
12 Months Ended
Jan. 26, 2025
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]  
Schedule II - Valuation and Qualifying Accounts
Schedule II – Valuation and Qualifying Accounts
DescriptionBalance at
Beginning of Period
Additions Deductions Balance at
End of Period
 (In millions)
Fiscal year 2025
      
Allowance for doubtful accounts$$— (1)$— (1)$
Sales return allowance$109 $151 (2)$(178)(4)$82 
Deferred tax valuation allowance$1,552 $58 (3)$— $1,610 
Fiscal year 2024
      
Allowance for doubtful accounts$$— (1)$— (1)$
Sales return allowance$26 $213 (2)$(130)(4)$109 
Deferred tax valuation allowance$1,484 $162 (3)$(94)(3)$1,552 
Fiscal year 2023
     
Allowance for doubtful accounts$$— (1)$— (1)$
Sales return allowance$13 $104 (2)$(91)(4)$26 
Deferred tax valuation allowance$907 $577 (3)$— $1,484 
(1)Additions represent either expense or acquired balances and deductions represent write-offs.
(2)Additions represent estimated product returns charged as a reduction to revenue or an acquired balance.
(3)Additional valuation allowance on deferred tax assets not likely to be realized. Additions represent additional valuation allowance on capital loss carryforwards, and certain state and other deferred tax assets. Deductions represent the release of valuation allowance on certain state deferred tax assets. Refer to Note 13 of the Notes to the Consolidated Financial Statements in Part IV, Item 15 of this Annual Report on Form 10-K for additional information.
(4)Represents sales returns.
v3.25.0.1
Pay vs Performance Disclosure - USD ($)
$ in Millions
12 Months Ended
Jan. 26, 2025
Jan. 28, 2024
Jan. 29, 2023
Pay vs Performance Disclosure      
Net income $ 72,880 $ 29,760 $ 4,368
v3.25.0.1
Insider Trading Arrangements
3 Months Ended 12 Months Ended
Jan. 26, 2025
shares
Jan. 26, 2025
shares
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement  
The following members of our Board of Directors and/or officers adopted, modified or terminated a trading arrangement that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), or a Rule 10b5-1 Trading Arrangement:
NameTitle of Director or OfficerActionDateTotal Shares of Common Stock to be SoldExpiration Date
Aarti ShahDirectorTerminationNovember 25, 2024
29,000*
N/A
Aarti ShahDirectorAdoptionNovember 25, 202439,000March 31, 2026
John O. DabiriDirectorAdoptionDecember 9, 2024
3,396**
December 2, 2025
*The Rule 10b5-1 Trading Arrangement was adopted on September 27, 2024 for sales through March 31, 2026. No shares were sold under the plan prior to termination.
**Estimated assuming our closing stock price as of January 24, 2025. The number of shares is based on an estimate because the plan specifies a formulaic dollar amount of shares to be sold.
Non-Rule 10b5-1 Arrangement Adopted false  
Non-Rule 10b5-1 Arrangement Terminated false  
John O. Dabiri [Member]    
Trading Arrangements, by Individual    
Name John O. Dabiri  
Title members of our Board of Directors  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date December 9, 2024  
Expiration Date December 2, 2025  
Arrangement Duration 358 days  
Aggregate Available 3,396 3,396
Aarti Shah November 25, 2024 10b5-1 Trading arrangement [Member] | Ms Aarti Shah [Member]    
Trading Arrangements, by Individual    
Name Aarti Shah  
Title members of our Board of Directors  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date November 25, 2024  
Expiration Date March 31, 2026  
Arrangement Duration 491 days  
Aggregate Available 39,000 39,000
Aarti Shah September 27, 2024 10b5-1 Trading arrangement [Member] | Ms Aarti Shah [Member]    
Trading Arrangements, by Individual    
Name Aarti Shah  
Title members of our Board of Directors  
Rule 10b5-1 Arrangement Terminated true  
Termination Date November 25, 2024  
Aggregate Available 29,000 29,000
v3.25.0.1
Insider Trading Policies and Procedures
12 Months Ended
Jan. 26, 2025
Insider Trading Policies and Procedures [Line Items]  
Insider Trading Policies and Procedures Adopted true
v3.25.0.1
Cybersecurity Risk Management and Strategy Disclosure
12 Months Ended
Jan. 26, 2025
Cybersecurity Risk Management, Strategy, and Governance [Line Items]  
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]
We have in place certain infrastructure, systems, policies, and procedures that are designed to proactively and reactively address circumstances that arise when unexpected events such as a cybersecurity incident occur. These include processes for assessing, identifying, and managing material risks from cybersecurity threats. Our information security management program generally follows processes outlined in frameworks such as the ISO 27001 international standard for Information Security and we evaluate and evolve our security measures as appropriate. We consult with external parties, such as cybersecurity firms and risk management and governance experts, on risk management and strategy.
Identifying, assessing, and managing cybersecurity risk is integrated into our overall risk management systems and processes, and we have in place cybersecurity and data privacy training and policies designed to (a) respond to new requirements in global privacy and cybersecurity laws and (b) prevent, detect, respond to, mitigate and recover from identified and significant cybersecurity threats.
We also have a vendor risk assessment process consisting of, depending on the nature and sensitivity of the supplier and data they process on our behalf, the distribution and review of supplier questionnaires designed to help us evaluate cybersecurity risks that we may encounter when working with third parties that have access to confidential and other sensitive company information. We take steps designed to ensure that such vendors have implemented data privacy and security controls that help mitigate the cybersecurity risks associated with these vendors, depending on the nature and sensitivity of the supplier and data they process on our behalf. We routinely assess our high-risk suppliers’ conformance to industry standards (e.g., ISO 27001, ISO 28001, and C-TPAT), and we evaluate them for additional information, product, and physical security requirements.
Refer to “Item 1A. Risk factors” in this annual report on Form 10-K for additional information about cybersecurity-related risks.
Cybersecurity Risk Management Processes Integrated [Flag] true
Cybersecurity Risk Management Processes Integrated [Text Block]
Identifying, assessing, and managing cybersecurity risk is integrated into our overall risk management systems and processes, and we have in place cybersecurity and data privacy training and policies designed to (a) respond to new requirements in global privacy and cybersecurity laws and (b) prevent, detect, respond to, mitigate and recover from identified and significant cybersecurity threats.
Cybersecurity Risk Management Third Party Engaged [Flag] true
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag] true
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag] false
Cybersecurity Risk Board of Directors Oversight [Text Block]
Information security matters, including managing and assessing risks from cybersecurity threats, remain under the oversight of the Company’s Board of Directors, or the Board. The Audit Committee of the Board, or the Audit Committee, also reviews the adequacy and effectiveness of the Company’s information security policies and practices and the internal controls regarding information security risks. The Audit Committee receives regular information security updates from management, including our Chief Security Officer and members of our security team. The Board also receives annual reports on information security matters from our Chief Security Officer and members of our security team.
Our security efforts are managed by a team of executive cybersecurity, IT, engineering, operations, and legal professionals. We have established a cross-functional leadership team, consisting of executive-level leaders, that meets regularly to review cybersecurity matters and evaluate emerging threats. With oversight and guidance provided by the cross-functional leadership team, our information security teams refine our practices to address emerging security risks and changes in regulations. Our executive-level leadership team also participates in cybersecurity incident response efforts by engaging with the incident response team and helping direct the company’s response to and assessment of certain cybersecurity incidents.
We have designated a Chief Security Officer that reports to our Senior Vice President of Software Engineering to manage our assessment and management of material risks from cybersecurity threats. Our Chief Security Officer’s cybersecurity expertise includes over 17 years of combined government and private sector assignments.
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block] Information security matters, including managing and assessing risks from cybersecurity threats, remain under the oversight of the Company’s Board of Directors, or the Board. The Audit Committee of the Board, or the Audit Committee, also reviews the adequacy and effectiveness of the Company’s information security policies and practices and the internal controls regarding information security risks.
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block] The Audit Committee receives regular information security updates from management, including our Chief Security Officer and members of our security team. The Board also receives annual reports on information security matters from our Chief Security Officer and members of our security team.
Cybersecurity Risk Role of Management [Text Block]
Our security efforts are managed by a team of executive cybersecurity, IT, engineering, operations, and legal professionals. We have established a cross-functional leadership team, consisting of executive-level leaders, that meets regularly to review cybersecurity matters and evaluate emerging threats. With oversight and guidance provided by the cross-functional leadership team, our information security teams refine our practices to address emerging security risks and changes in regulations. Our executive-level leadership team also participates in cybersecurity incident response efforts by engaging with the incident response team and helping direct the company’s response to and assessment of certain cybersecurity incidents.
Cybersecurity Risk Management Positions or Committees Responsible [Flag] true
Cybersecurity Risk Management Positions or Committees Responsible [Text Block] We have designated a Chief Security Officer that reports to our Senior Vice President of Software Engineering to manage our assessment and management of material risks from cybersecurity threats
Cybersecurity Risk Management Expertise of Management Responsible [Text Block] Our Chief Security Officer’s cybersecurity expertise includes over 17 years of combined government and private sector assignments.
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block] We have designated a Chief Security Officer that reports to our Senior Vice President of Software Engineering to manage our assessment and management of material risks from cybersecurity threats
Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag] true
v3.25.0.1
Organization and Summary of Significant Accounting Policies (Policies)
12 Months Ended
Jan. 26, 2025
Accounting Policies [Abstract]  
Our Company
Our Company
Headquartered in Santa Clara, California, NVIDIA was incorporated in California in April 1993 and reincorporated in Delaware in April 1998.
All references to “NVIDIA,” “we,” “us,” “our” or the “Company” mean NVIDIA Corporation and its subsidiaries.
Certain prior fiscal year balances have been reclassified to conform to the current fiscal year presentation.
In June 2024, we executed a ten-for-one stock split of our common stock. All share, equity award, and per share amounts and related shareholders' equity balances presented herein have been retroactively adjusted to reflect the Stock Split.
Fiscal Year
Fiscal Year
We operate on a 52- or 53-week year, ending on the last Sunday in January. Fiscal years 2025, 2024 and 2023 were all 52-week years.
Principles of Consolidation
Principles of Consolidation
Our consolidated financial statements include the accounts of NVIDIA Corporation and our wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates
Use of Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from our estimates. On an on-going basis, we evaluate our estimates, including those related to accounts receivable, cash equivalents and marketable securities, goodwill, income taxes, inventories and product purchase commitments, investigation and settlement costs, litigation, non-marketable equity securities, other contingencies, property, plant, and equipment, restructuring and other charges, revenue recognition, and stock-based compensation. These estimates are based on historical facts and various other assumptions that we believe are reasonable.
Revenue Recognition
Revenue Recognition
We derive our revenue from product sales, including hardware and systems, license and development arrangements, software licensing, and cloud services. We determine revenue recognition through the following steps: (1) identification of the contract with a customer; (2) identification of the performance obligations in the contract; (3) determination of the transaction price; (4) allocation of the transaction price to the performance obligations in the contract (where revenue is allocated on a relative standalone selling price basis by maximizing the use of observable inputs to determine the standalone selling price for each performance obligation); and (5) recognition of revenue when, or as, we satisfy a performance obligation. Payment from customers, per our standard payment terms, is generally due shortly after delivery of products, availability of software licenses or commencement of services.
Product Sales Revenue
Revenue from product sales is recognized upon transfer of control of products to customers in an amount that reflects the consideration we expect to receive in exchange for those products. Certain products are sold with support or an extended warranty for the incorporated system, hardware, and/or software. Support and extended warranty revenue are recognized ratably over the service period, or as services are performed. Revenue is recognized net of allowances for returns, customer programs and any taxes collected from customers.
For products sold with a right of return, we record a reduction to revenue by establishing a sales return allowance for estimated product returns at the time revenue is recognized, based primarily on historical return rates. However, if product returns for a fiscal period are anticipated to exceed historical return rates, we may determine that additional sales return allowances are required to accurately reflect our estimated exposure for product returns.
Our customer programs involve rebates, which are designed to serve as sales incentives to resellers of our products in various target markets, and MDFs which represent monies paid to our partners that are earmarked for market segment development and are designed to support our partners’ activities while also promoting NVIDIA products. We account for customer programs as a reduction to revenue and accrue for such programs for potential rebates and MDFs based on the amount we expect to be claimed by customers.
License and Development Arrangements
Our license and development arrangements with customers typically require significant customization of our IP components. As a result, we recognize the revenue from the license and the revenue from the development services as a single performance obligation over the period in which the development services are performed. We measure progress to completion based on actual cost incurred to date as a percentage of the estimated total cost required to complete each project. If a loss on an arrangement becomes probable during a period, we record a provision for such loss in that period.
Software Licensing
Our software licenses provide our customers with a right to use the software when it is made available to the customer. Customers may purchase either perpetual licenses or subscriptions to licenses, which differ mainly in the duration over which the customer benefits from the software. Software licenses are frequently sold along with support, which includes the right to receive, on a when-and-if available basis, future unspecified software updates and upgrades. Revenue from software licenses is recognized up front when the software is made available to the customer. Software support revenue is recognized ratably over the service period, or as services are performed.
Cloud Services
Cloud services, which allow customers to use hosted software and hardware infrastructure without taking possession of the software or hardware, are provided on a subscription basis or a combination of subscription plus usage. Revenue related to subscription-based cloud services is recognized ratably over the contract period. Revenue related to cloud services based on usage is recognized as usage occurs. Cloud services are typically sold on a standalone basis, but certain offerings may be sold with hardware and/or software and related support.
Contracts with Multiple Performance Obligations
Our contracts may contain more than one of the products and services listed above, each of which is separately accounted for as a distinct performance obligation. We account for multiple agreements with a single customer as a single contract if the contractual terms and/or substance of those agreements indicate that they may be so closely related that they are, in effect, parts of a single contract.
We allocate the total transaction price to each distinct performance obligation in an arrangement with multiple performance obligations on a relative standalone selling price basis. The standalone selling price reflects the price we would charge for a specific product or service if it were sold separately in similar circumstances and to similar customers. When determining standalone selling price, we maximize the use of observable inputs.
Product Warranties
Product Warranties
We offer a limited warranty to end-users ranging from one to three years for products to repair or replace products for manufacturing defects or hardware component failures. Cost of revenue includes the estimated cost of product warranties that are calculated at the point of revenue recognition. Under limited circumstances, we may offer an extended limited warranty to customers for certain products. We also accrue for known warranty and indemnification issues if a loss is probable and can be reasonably estimated.
Stock-based Compensation
Stock-based Compensation
We use the closing trading price of our common stock on the date of grant, minus a dividend yield discount, as the fair value of awards of restricted stock units, or RSUs, and performance stock units, or PSUs, that are based on our corporate financial performance targets. We use a Monte Carlo simulation on the date of grant to estimate the fair value of PSUs that are based on our stock performance compared to market performance, or market-based PSUs. The compensation expense for RSUs and market-based PSUs is recognized using a straight-line attribution method over the requisite employee service period while compensation expense for PSUs is recognized using an accelerated amortization model based on performance targets probable of achievement. We estimate the fair value of shares to be issued under our employee stock purchase plan, or ESPP, using the Black-Scholes model at the commencement of an offering period in March and September of each year. Stock-based compensation for our ESPP is expensed using an accelerated amortization model. Additionally, for RSUs, PSUs, and market-based PSUs, we estimate expected forfeitures based on our historical forfeitures.
Litigation, Investigation and Settlement Costs
Litigation, Investigation and Settlement Costs
We currently, are, and will likely continue to be subject to claims, litigation, and other actions, including potential regulatory proceedings, involving patent and other intellectual property matters, taxes, labor and employment, competition and antitrust, commercial disputes, goods and services offered by us and by third parties, and other matters. There are many uncertainties associated with any litigation or investigation, and we cannot be certain that these actions or other third-party claims against us will be resolved without litigation, fines and/or substantial settlement payments or judgments. If information becomes available that causes us to determine that a loss in any of our pending litigation,
investigations or settlements is probable, and we can reasonably estimate the loss associated with such events, we will record the loss. However, the actual liability in any such litigation or investigation may be materially different from our estimates, which could require us to record additional costs. If we determine that a loss is reasonably possible and the loss or range of loss can be estimated, we disclose the reasonably possible loss.
Foreign Currency Remeasurement
Foreign Currency Remeasurement
We use the U.S. dollar as our functional currency for our subsidiaries. Foreign currency monetary assets and liabilities are remeasured into United States dollars at end-of-period exchange rates. Non-monetary assets and liabilities such as property and equipment and equity are remeasured at historical exchange rates. Revenue and expenses are remeasured at exchange rates in effect during each period, except for those expenses related to non-monetary balance sheet amounts, which are remeasured at historical exchange rates. Gains or losses from foreign currency remeasurement are included in earnings in our Consolidated Statements of Income and to date have not been significant.
Income Taxes
Income Taxes
We recognize federal, state and foreign current tax liabilities or assets based on our estimate of taxes payable or refundable in the current fiscal year by tax jurisdiction. We recognize federal, state and foreign deferred tax assets or liabilities, as appropriate, for our estimate of future tax effects attributable to temporary differences and carryforwards; and we record a valuation allowance to reduce any deferred tax assets by the amount of any tax benefits that, based on available evidence and judgment, are not expected to be realized.
Our calculation of deferred tax assets and liabilities is based on certain estimates and judgments and involves dealing with uncertainties in the application of complex tax laws. Our estimates of deferred tax assets and liabilities may change based, in part, on added certainty or finality to an anticipated outcome, changes in accounting standards or tax laws in the U.S., or foreign jurisdictions where we operate, or changes in other facts or circumstances. In addition, we recognize liabilities for potential U.S. and foreign income tax contingencies based on our estimate of whether, and the extent to which, additional taxes may be due. If we determine that payment of these amounts is unnecessary or if the recorded tax liability is less than our current assessment, we may be required to recognize an income tax benefit or additional income tax expense in our financial statements accordingly.
As of January 26, 2025, we had a valuation allowance of $1.6 billion related to capital loss carryforwards, and certain state and other deferred tax assets that management determined are not likely to be realized due, in part, to jurisdictional projections of future taxable income, including capital gains. To the extent realization of the deferred tax assets becomes more-likely-than-not, we would recognize such deferred tax assets as income tax benefits during the period.
We recognize the benefit from a tax position only if it is more-likely-than-not that the position would be sustained upon audit based solely on the technical merits of the tax position. Our policy is to include interest and penalties related to unrecognized tax benefits as a component of income tax expense.
Net Income Per Share
Net Income Per Share
Basic net income per share is computed using the weighted average number of common shares outstanding during the period. Diluted net income per share is computed using the weighted average number of common and potentially dilutive shares outstanding during the period, using the treasury stock method. Any anti-dilutive effect of equity awards outstanding is not included in the computation of diluted net income per share.
Cash and Cash Equivalents and Marketable Securities
Cash and Cash Equivalents and Marketable Securities
We consider all highly liquid investments that are readily convertible into cash and have an original maturity of three months or less at the time of purchase to be cash equivalents. Marketable securities consist of highly liquid debt investments with maturities of greater than three months when purchased and publicly-held equity securities. We classify these investments as current based on the nature of the investments and their availability for use in current operations.
We classify our cash equivalents and marketable debt securities at the date of acquisition as available-for-sale. These available-for-sale debt securities are reported at fair value with the related unrealized gains and losses included in accumulated other comprehensive income or loss, a component of shareholders’ equity, net of tax. The fair value of interest-bearing debt securities includes accrued interest. Realized gains and losses on the sale of marketable securities are determined using the specific-identification method and recorded in the Other income (expense), net, section of our Consolidated Statements of Income.
Available-for-sale debt securities are subject to impairment review. If the estimated fair value of available-for-sale debt securities is less than its amortized cost basis, we determine if the difference, if any, is caused by expected credit losses and write-down the amortized cost basis of the securities if it is more likely than not we will be required or we intend to
sell the securities before recovery of its amortized cost basis. Allowances for credit losses and write-downs are recognized in the Other income (expense), net section of our Consolidated Statements of Income.
Publicly-held equity securities have readily determinable fair values with changes in fair value recorded in Other income (expense), net.
Cash and Cash Equivalents and Marketable Securities
Cash and Cash Equivalents and Marketable Securities
We consider all highly liquid investments that are readily convertible into cash and have an original maturity of three months or less at the time of purchase to be cash equivalents. Marketable securities consist of highly liquid debt investments with maturities of greater than three months when purchased and publicly-held equity securities. We classify these investments as current based on the nature of the investments and their availability for use in current operations.
We classify our cash equivalents and marketable debt securities at the date of acquisition as available-for-sale. These available-for-sale debt securities are reported at fair value with the related unrealized gains and losses included in accumulated other comprehensive income or loss, a component of shareholders’ equity, net of tax. The fair value of interest-bearing debt securities includes accrued interest. Realized gains and losses on the sale of marketable securities are determined using the specific-identification method and recorded in the Other income (expense), net, section of our Consolidated Statements of Income.
Available-for-sale debt securities are subject to impairment review. If the estimated fair value of available-for-sale debt securities is less than its amortized cost basis, we determine if the difference, if any, is caused by expected credit losses and write-down the amortized cost basis of the securities if it is more likely than not we will be required or we intend to
sell the securities before recovery of its amortized cost basis. Allowances for credit losses and write-downs are recognized in the Other income (expense), net section of our Consolidated Statements of Income.
Publicly-held equity securities have readily determinable fair values with changes in fair value recorded in Other income (expense), net.
Fair Value of Financial Instruments
Fair Value of Financial Instruments
The carrying value of cash equivalents, accounts receivable, accounts payable and accrued liabilities approximate their fair values due to their relatively short maturities as of January 26, 2025 and January 28, 2024. Marketable debt and equity securities are reported at fair value based on quoted market prices. Derivative instruments are recognized as either assets or liabilities and are measured at fair value. The accounting for changes in the fair value of a derivative depends on the intended use of the derivative and the resulting designation. For fair value hedges, the gains or losses are recognized in earnings in the periods of change together with the offsetting losses or gains on the hedged items attributed to the risk being hedged. For derivative instruments designated as accounting hedges, the effective portion of the gains or losses on the derivatives is initially reported as a component of other comprehensive income or loss and is subsequently recognized in earnings when the hedged exposure is recognized in earnings. For derivative instruments not designated as accounting hedges, changes in fair value are recognized in earnings.
Concentration of Credit Risk
Concentration of Credit Risk
Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash equivalents, marketable securities, and accounts receivable. Our investment policy requires the purchase of highly-rated fixed income securities, the diversification of investment type and credit exposures, and includes certain limits on our portfolio maturities. We perform ongoing credit evaluations of our customers’ financial condition and maintain an allowance for potential credit losses. This allowance consists of an amount identified for specific customers and an amount based on overall estimated exposure. Our overall estimated exposure excludes amounts covered by credit insurance and letters of credit.
Inventories
Inventories
Inventory cost is computed on an adjusted standard basis, which approximates actual cost on an average or first-in, first-out basis. Inventory costs consist primarily of the cost of semiconductors, including wafer fabrication, assembly, testing and packaging, manufacturing support costs, including labor and overhead associated with such purchases, final test yield fallout, and shipping costs, as well as the cost of purchased memory products and other component parts. We charge cost of sales for inventory provisions to write-down our inventory to the lower of cost or net realizable value or for obsolete or excess inventory, and for excess product purchase commitments. Most of our inventory provisions relate to excess quantities of products, based on our inventory levels and future product purchase commitments compared to assumptions about future demand and market conditions. Once inventory has been written-off or written-down, it creates a new cost basis for the inventory that is not subsequently written-up. We record a liability for noncancelable purchase commitments with suppliers for quantities in excess of our future demand forecasts consistent with our valuation of obsolete or excess inventory.
Property and Equipment
Property and Equipment
Property and equipment are stated at cost less accumulated depreciation. Depreciation of property and equipment is computed using the straight-line method based on the estimated useful lives of the assets of two to seven years. Once an asset is identified for retirement or disposition, the related cost and accumulated depreciation or amortization are removed, and a gain or loss is recorded. The estimated useful lives of our buildings are up to thirty years. Depreciation expense includes the amortization of assets recorded under finance leases. Leasehold improvements and assets recorded under finance leases are amortized over the shorter of the expected lease term or the estimated useful life of the asset.
Leases
Leases
We determine if an arrangement is or contains a lease at inception. Operating leases with lease terms of more than 12 months are included in operating lease assets, accrued and other current liabilities, and long-term operating lease liabilities on our consolidated balance sheet. Operating lease assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments over the lease term.
Operating lease assets and liabilities are recognized based on the present value of the remaining lease payments discounted using our incremental borrowing rate. Operating lease assets also include initial direct costs incurred and prepaid lease payments, minus any lease incentives. Our lease terms include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense is recognized on a straight-line basis over the lease term.
Goodwill
Goodwill
Goodwill is subject to our annual impairment test during the fourth quarter of our fiscal year, or earlier if indicators of potential impairment exist. In completing our impairment test, we perform either a qualitative or a quantitative analysis on a reporting unit basis.
Qualitative factors include industry and market considerations, overall financial performance, and other relevant events and factors affecting the reporting units.
The quantitative impairment test considers both the income approach and the market approach to estimate a reporting unit’s fair value. The income and market valuation approaches consider factors that include, but are not limited to, prospective financial information, growth rates, residual values, discount rates and comparable multiples from publicly traded companies in our industry and require us to make certain assumptions and estimates regarding industry economic factors and the future profitability of our business.
Intangible Assets and Other Long-Lived Assets
Intangible Assets and Other Long-Lived Assets
Intangible assets primarily represent acquired intangible assets including developed technology and customer relationships, as well as rights acquired under technology licenses, patents, and acquired IP. We currently amortize our intangible assets with finite lives over periods ranging from one to twenty years using a method that reflects the pattern in which the economic benefits of the intangible asset are consumed or otherwise used up or, if that pattern cannot be reliably determined, using a straight-line amortization method.
Long-lived assets, such as property and equipment and intangible assets subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable. The recoverability of assets or asset groups to be held and used is measured by a comparison of the carrying amount of an asset or asset group to estimated undiscounted future cash flows expected to be generated by the asset or asset group. If the carrying amount of an asset or asset group exceeds its estimated future cash flows, an impairment charge is recognized for the amount by which the carrying amount of the asset or asset group exceeds the estimated fair value of the asset or asset group. Fair value is determined based on the estimated discounted future cash flows expected to be generated by the asset or asset group. Assets and liabilities to be disposed of would be separately presented in the Consolidated Balance Sheet and the assets would be reported at the lower of the carrying amount or fair value less costs to sell, and would no longer be depreciated.
Business Combination
Business Combination
We allocate the fair value of the purchase price of an acquisition to the tangible assets acquired, liabilities assumed, and intangible assets acquired, based on their estimated fair values. The excess of the fair value of the purchase price over the fair values of these net tangible and intangible assets acquired is recorded as goodwill. Management’s estimates of fair value are based upon assumptions believed to be reasonable, but our estimates and assumptions are inherently uncertain and subject to refinement. The estimates and assumptions used in valuing intangible assets include, but are not limited to, the amount and timing of projected future cash flows, discount rate used to determine the present value of these cash flows and asset lives. These estimates are inherently uncertain and, therefore, actual results may differ from the estimates made. As a result, during the measurement period of up to one year from the acquisition date, we may record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the measurement period's conclusion or final determination of the fair value of the purchase price of an acquisition, whichever comes first, any subsequent adjustments are recorded to our Consolidated Statements of Income.
Acquisition-related expenses are recognized separately from the business combination and expensed as incurred.
Non-marketable Equity Securities
Non-Marketable Equity Securities
Non-marketable equity securities consist of investments in privately-held companies that do not have a readily determinable fair value. These investments are measured at cost minus impairment, if any, and are adjusted for changes resulting from observable price changes in orderly transactions for an identical or similar investment in the same issuer, or the measurement alternative. Fair value is based upon observable inputs in an inactive market and the valuation requires our judgment due to the absence of market prices and inherent lack of liquidity. All gains and losses on these investments, realized and unrealized, are recognized in other income (expense), net on our Consolidated Statements of Income.
We assess whether an impairment loss has occurred on our investments in non-marketable equity securities, accounted for under the measurement alternative based on quantitative and qualitative factors. If any impairment is identified for non-marketable equity securities, we write down the investment to its fair value and record the corresponding charge through other income (expense), net on our Consolidated Statements of Income.
Recently Issued Accounting Pronouncements
Recently Issued Accounting Pronouncements
Recently Adopted Accounting Pronouncement
In November 2023, the Financial Accounting Standards Board, or FASB, issued a new accounting standard requiring disclosures of significant expenses in operating segments. We adopted this standard in our fiscal year 2025 annual report. Refer to Note 16 of the Notes to the Consolidated Financial Statements in Part IV, Item 15 of this Annual Report on Form 10-K for further information.
Recent Accounting Pronouncements Not Yet Adopted
In December 2023, the FASB issued a new accounting standard which includes new and updated income tax disclosures, including disaggregation of information in the rate reconciliation and income taxes paid. We expect to adopt this standard in our fiscal year 2026 annual report. We do not expect the adoption of this standard to have a material impact on our Consolidated Financial Statements other than additional disclosures.
In November 2024, the FASB issued a new accounting standard requiring disclosures of certain additional expense information on an annual and interim basis, including, among other items, the amounts of purchases of inventory, employee compensation, depreciation and intangible asset amortization included within each income statement expense caption, as applicable. We expect to adopt this standard in our fiscal year 2028 annual report. We do not expect the adoption of this standard to have a material impact on our Consolidated Financial Statements other than additional disclosures.
v3.25.0.1
Stock-Based Compensation (Tables)
12 Months Ended
Jan. 26, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-Based Compensation Expense, Net of Amounts Capitalized as Inventory
Consolidated Statements of Income include stock-based compensation expense, net of amounts capitalized into inventory and subsequently recognized to cost of revenue, as follows:
 Year Ended
Jan 26, 2025Jan 28, 2024Jan 29, 2023
 (In millions)
Cost of revenue$178 $141 $138 
Research and development3,423 2,532 1,892 
Sales, general and administrative1,136 876 680 
Total$4,737 $3,549 $2,710 
Schedule of Equity Awards
The following is a summary of equity awards granted under our equity incentive plans:
Year Ended
Jan 26, 2025Jan 28, 2024Jan 29, 2023
(In millions, except per share data)
RSUs, PSUs and Market-based PSUs
Awards granted89 140 250 
Estimated total grant-date fair value$7,834 $5,316 $4,505 
Weighted average grant-date fair value per share$87.99 $37.41 $18.37 
ESPP
Shares purchased30 30 30 
Weighted average price per share$17.74 $15.81 $12.25 
Weighted average grant-date fair value per share$8.61 $6.99 $5.19 
Schedule of ESPP Valuation Assumptions
The fair value of shares issued under our ESPP have been estimated with the following assumptions:
 Year Ended
 Jan 26, 2025Jan 28, 2024Jan 29, 2023
(Using the Black-Scholes model)
ESPP
Weighted average expected life (in years)
0.1-2.0
0.1-2.0
0.1-2.0
Risk-free interest rate
3.6%-5.4%
3.9%-5.5%
—%-4.6%
Volatility
31%-75%
31%-67%
43%-72%
Dividend yield
0.03%
0.06%
0.09%
Schedule of Equity Award Transactions
The following is a summary of our equity award transactions under our equity incentive plans: 
RSUs, PSUs and Market-based PSUs Outstanding
 Number of Shares
Weighted Average Grant-Date Fair Value Per Share
(In millions, except per share data)
Balance as of Jan 28, 2024
367 $24.59 
Granted89 $87.99 
Vested(173)$24.89 
Canceled and forfeited(9)$32.10 
Balance as of Jan 26, 2025
274 $44.75 
Vested and expected to vest after Jan 26, 2025
272 $44.59 
v3.25.0.1
Net Income Per Share (Tables)
12 Months Ended
Jan. 26, 2025
Earnings Per Share [Abstract]  
Schedule of Reconciliation of Numerators and Denominators of Basic and Diluted net Income Per Share Computations
The following is a reconciliation of the denominator of the basic and diluted net income per share computations for the periods presented:
 Year Ended
 Jan 26, 2025Jan 28, 2024Jan 29, 2023
 (In millions, except per share data)
Numerator:   
Net income$72,880 $29,760 $4,368 
Denominator:
Basic weighted average shares24,555 24,690 24,870 
Dilutive impact of outstanding equity awards249 250 200 
Diluted weighted average shares24,804 24,940 25,070 
Net income per share:
Basic (1)$2.97 $1.21 $0.18 
Diluted (2)$2.94 $1.19 $0.17 
Anti-dilutive equity awards excluded from diluted net income per share
51 150 400 
(1)    Net income divided by basic weighted average shares.
(2)    Net income divided by diluted weighted average shares.
v3.25.0.1
Amortizable Intangible Assets (Tables)
12 Months Ended
Jan. 26, 2025
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of the Components of Our Amortizable Intangible Assets
The components of our amortizable intangible assets are as follows:
 Jan 26, 2025Jan 28, 2024
 Gross
Carrying
Amount
Accumulated
Amortization
Net 
Carrying
Amount
Gross
Carrying
Amount
Accumulated
Amortization
Net 
Carrying
Amount
 (In millions)
Acquisition-related intangible assets$2,900 $(2,264)$636 $2,642 $(1,720)$922 
Patents and licensed technology449 (278)171 449 (259)190 
Total intangible assets$3,349 $(2,542)$807 $3,091 $(1,979)$1,112 
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense
The following table outlines the estimated future amortization expense related to the net carrying amount of intangible assets as of January 26, 2025:
Future Amortization Expense
 (In millions)
Fiscal Year: 
2026$354 
2027236 
202884 
202931 
203010 
2031 and thereafter92 
Total$807 
v3.25.0.1
Cash Equivalents and Marketable Securities (Tables)
12 Months Ended
Jan. 26, 2025
Investments, Debt and Equity Securities [Abstract]  
Schedule of Cash Equivalents and Marketable Securities
The following is a summary of cash equivalents and marketable securities:
 Jan 26, 2025
Amortized
Cost
Unrealized
Gain
Unrealized
Loss
Estimated
Fair Value
Reported as
 Cash EquivalentsMarketable Securities
 (In millions)
Corporate debt securities$18,504 $51 $(29)$18,526 $2,071 $16,455 
Debt securities issued by the U.S. Treasury16,749 42 (22)16,769 1,801 14,968 
Money market funds3,760 — — 3,760 3,760 — 
Debt securities issued by U.S. government agencies2,775 (5)2,777 — 2,777 
Foreign government bonds177 — — 177 137 40 
Certificates of deposit97 — — 97 97 — 
Total debt securities with fair value adjustments recorded in other comprehensive income42,062 100 (56)42,106 7,866 34,240 
Publicly-held equity securities (1)381 — 381 
Total$42,062 $100 $(56)$42,487 $7,866 $34,621 
(1)    Fair value adjustments on publicly-held equity securities are recorded in net income. Beginning in the second quarter of fiscal year 2025, publicly-held equity securities from investments in non-affiliated entities included in other assets (long term) were classified in marketable securities on our Consolidated Balance Sheets.
 Jan 28, 2024
Amortized
Cost
Unrealized
Gain
Unrealized
Loss
Estimated
Fair Value
Reported as
 Cash EquivalentsMarketable Securities
 (In millions)
Corporate debt securities$10,126 $31 $(5)$10,152 $2,231 $7,921 
Debt securities issued by the U.S. Treasury9,517 17 (10)9,524 1,315 8,209 
Money market funds3,031 — — 3,031 3,031 — 
Debt securities issued by U.S. government agencies2,326 (1)2,333 89 2,244 
Certificates of deposit510 — — 510 294 216 
Foreign government bonds174 — — 174 60 114 
Total debt securities with fair value changes recorded in other comprehensive income$25,684 $56 $(16)$25,724 $7,020 $18,704 
The amortized cost and estimated fair value of debt securities included in cash equivalents and marketable securities are shown below by contractual maturity.
 Jan 26, 2025Jan 28, 2024
 Amortized
Cost
Estimated
Fair Value
Amortized
Cost
Estimated
Fair Value
 (In millions)
Less than one year$18,426 $18,450 $16,336 $16,329 
Due in 1 - 5 years23,636 23,656 9,348 9,395 
Total$42,062 $42,106 $25,684 $25,724 
Schedule of Marketable Securities in a Continuous Unrealized Loss Position
The following tables provide the breakdown of unrealized losses, aggregated by investment category and length of time that individual debt securities have been in a continuous loss position:
Jan 26, 2025
 Less than 12 Months12 Months or GreaterTotal
 Estimated Fair ValueGross Unrealized LossEstimated Fair ValueGross Unrealized LossEstimated Fair ValueGross Unrealized Loss
 (In millions)
Debt securities issued by the U.S. Treasury$6,315 $(22)$177 $— $6,492 $(22)
Corporate debt securities5,291 (29)15 — 5,306 (29)
Debt securities issued by U.S. government agencies816 (5)21 — 837 (5)
Total$12,422 $(56)$213 $— $12,635 $(56)
Jan 28, 2024
 Less than 12 Months12 Months or GreaterTotal
 Estimated Fair ValueGross Unrealized LossEstimated Fair ValueGross Unrealized LossEstimated Fair ValueGross Unrealized Loss
 (In millions)
Debt securities issued by the U.S. Treasury$3,343 $(5)$1,078 $(5)$4,421 $(10)
Corporate debt securities1,306 (3)618 (2)1,924 (5)
Debt securities issued by U.S. government agencies670 (1)— — 670 (1)
Total$5,319 $(9)$1,696 $(7)$7,015 $(16)
v3.25.0.1
Fair Value of Financial Assets and Liabilities and Non-marketable Equity Securities (Tables)
12 Months Ended
Jan. 26, 2025
Fair Value Disclosures [Abstract]  
Schedule of Fair Value of Financial Assets and Liabilities
The fair values of our financial assets and liabilities are determined using quoted market prices of identical assets or market prices of similar assets from active markets. We review fair value classification on a quarterly basis.
Fair Value at
Pricing CategoryJan 26, 2025Jan 28, 2024
(In millions)
Assets
Cash equivalents and marketable securities:
Money market fundsLevel 1$3,760 $3,031 
Publicly-held equity securitiesLevel 1$381 $— 
Corporate debt securitiesLevel 2$18,526 $10,152 
Debt securities issued by the U.S. TreasuryLevel 2$16,769 $9,524 
Debt securities issued by U.S. government agenciesLevel 2$2,777 $2,333 
Foreign government bondsLevel 2$177 $174 
Certificates of depositLevel 2$97 $510 
Other assets:
Publicly-held equity securitiesLevel 1$— $225 
Liabilities (1)
0.584% Notes Due 2024
Level 2$— $1,228 
3.20% Notes Due 2026
Level 2$982 $970 
1.55% Notes Due 2028
Level 2$1,136 $1,115 
2.85% Notes Due 2030
Level 2$1,376 $1,367 
2.00% Notes Due 2031
Level 2$1,064 $1,057 
3.50% Notes Due 2040
Level 2$824 $851 
3.50% Notes Due 2050
Level 2$1,482 $1,604 
3.70% Notes Due 2060
Level 2$367 $403 
(1)    Liabilities are carried on our Consolidated Balance Sheets at their original issuance value, net of unamortized debt discount and issuance costs.
Equity Securities without Readily Determinable Fair Value
Adjustments to the carrying value of our non-marketable equity securities during fiscal years 2025 and 2024 were as follows:
Year Ended
Jan 26, 2025Jan 28, 2024
(In millions)
Balance at beginning of period$1,321 $288 
Adjustments related to non-marketable equity securities:
Net additions1,309 859 
Unrealized gains816 194 
Impairments and unrealized losses(59)(20)
Balance at end of period$3,387 $1,321 
v3.25.0.1
Balance Sheet Components (Tables)
12 Months Ended
Jan. 26, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Inventory
Certain balance sheet components are as follows:
 Jan 26, 2025Jan 28, 2024
Inventories:(In millions)
Raw materials$3,408 $1,719 
Work in process3,399 1,505 
Finished goods3,273 2,058 
Total inventories (1)$10,080 $5,282 
(1)    In fiscal years 2025 and 2024, we recorded an inventory provision of $1.6 billion and $774 million, respectively, in cost of revenue.
Schedule of Property and Equipment
 Jan 26, 2025Jan 28, 2024Estimated
Useful Life
Property and Equipment:(In millions)(In years)
Land$511 $218 (A)
Buildings, leasehold improvements, and furniture2,076 1,816 (B)
Equipment, compute hardware, and software7,568 5,200 
2-7
Construction in process529 189 (C)
Total property and equipment, gross10,684 7,423  
Accumulated depreciation and amortization(4,401)(3,509) 
Total property and equipment, net$6,283 $3,914  
(A)Land is a non-depreciable asset.
(B)The estimated useful lives of our buildings are up to thirty years. Leasehold improvements and finance leases are amortized based on the lesser of either the asset’s estimated useful life or the expected remaining lease term.
(C)Construction in process represents assets that are not available for their intended use as of the balance sheet date.
Schedule of Other Assets
 Jan 26, 2025Jan 28, 2024
Other Assets (Long Term):(In millions)
Non-marketable equity securities$3,387 $1,321 
Prepaid supply and capacity agreements (1)1,747 2,458 
Income tax receivable750 — 
Prepaid royalties340 364 
Other201 357 
Total other assets$6,425 $4,500 
(1)Prepaid supply and capacity agreements of $3.3 billion and $2.5 billion were included in Prepaid expenses and other current assets as of January 26, 2025 and January 28, 2024, respectively.
Schedule of Accrued and Other Current Liabilities
 Jan 26, 2025Jan 28, 2024
Accrued and Other Current Liabilities:(In millions)
Customer program accruals$4,880 $2,081 
Excess inventory purchase obligations (1)2,095 1,655 
Product warranty and return provisions1,373 415 
Taxes payable881 296 
Accrued payroll and related expenses848 675 
Deferred revenue (2)837 764 
Operating leases288 228 
Licenses and royalties175 182 
Unsettled share repurchases132 187 
Other228 199 
Total accrued and other current liabilities$11,737 $6,682 
(1)In fiscal years 2025 and 2024, we recorded an expense of approximately $2.0 billion and $1.4 billion, respectively, in cost of revenue.
(2)Includes customer advances and unearned revenue related to hardware support, software support, cloud services, and license and development arrangements. The balance as of January 26, 2025 and January 28, 2024 included $81 million and $233 million of customer advances, respectively.
Schedule of Other Long-term Liabilities
 Jan 26, 2025Jan 28, 2024
Other Long-Term Liabilities:(In millions)
Income tax payable (1)$2,188 $1,361 
Deferred revenue (2)976 573 
Deferred income tax886 462 
Licenses payable116 80 
Other79 65 
Total other long-term liabilities$4,245 $2,541 
(1)Income tax payable is comprised of the long-term portion of the one-time transition tax payable, unrecognized tax benefits, and related interest and penalties.
(2)Includes unearned revenue related to hardware support, software support and cloud services.
Schedule of Changes in Deferred Revenue
The following table shows the changes in short- and long-term deferred revenue during fiscal years 2025 and 2024:
 Jan 26, 2025Jan 28, 2024
(In millions)
Balance at beginning of period$1,337 $572 
Deferred revenue additions (1)5,083 2,038 
Revenue recognized (2)(4,607)(1,273)
Balance at end of period$1,813 $1,337 
(1)    Deferred revenue additions includes $3.6 billion and $783 million related to customer advances for fiscal years 2025 and 2024, respectively.
(2)    Revenue recognized includes $3.7 billion and $585 million related to customer advances for fiscal years 2025 and 2024, respectively.
v3.25.0.1
Derivative Financial Instruments (Tables)
12 Months Ended
Jan. 26, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Notional Value of Our Foreign Currency Forward Contracts Outstanding
The table below presents the notional value of our foreign currency contracts outstanding:
Jan 26, 2025Jan 28, 2024
 (In millions)
Designated as accounting hedges$1,424 $1,168 
Not designated as accounting hedges$1,297 $597 
v3.25.0.1
Debt (Tables)
12 Months Ended
Jan. 26, 2025
Debt Disclosure [Abstract]  
Schedule of Long-term Debt
Long-Term Debt
 Expected
Remaining Term (years)
Effective
Interest Rate
Jan 26, 2025Jan 28, 2024
   (In millions)
0.584% Notes Due 2024 (1)
0.66%$— $1,250 
3.20% Notes Due 2026
1.63.31%1,000 1,000 
1.55% Notes Due 2028
3.41.64%1,250 1,250 
2.85% Notes Due 2030
5.22.93%1,500 1,500 
2.00% Notes Due 2031
6.42.09%1,250 1,250 
3.50% Notes Due 2040
15.23.54%1,000 1,000 
3.50% Notes Due 2050
25.23.54%2,000 2,000 
3.70% Notes Due 2060
35.23.73%500 500 
Unamortized debt discount and issuance costs  (37)(41)
Net carrying amount  8,463 9,709 
Less short-term portion— (1,250)
Total long-term portion$8,463 $8,459 
(1)    In fiscal year 2025, we repaid the 0.584% Notes Due 2024.
v3.25.0.1
Commitments and Contingencies (Tables)
12 Months Ended
Jan. 26, 2025
Commitments and Contingencies Disclosure [Abstract]  
Schedule of Purchase Obligation, Fiscal Year Maturity
Total future purchase commitments as of January 26, 2025 are as follows:
Commitments
 (In millions)
Fiscal Year: 
2026$35,727 
20273,666 
20282,992 
20292,054 
2030422 
2031 and thereafter218 
Total$45,079 
Schedule of Product Warranty Activity The estimated product returns and product warranty activity consisted of the following:
Year Ended
Jan 26, 2025Jan 28, 2024Jan 29, 2023
(In millions)
Balance at beginning of period$306 $82 $46 
Additions1,203 278 145 
Utilization(219)(54)(109)
Balance at end of period$1,290 $306 $82 
v3.25.0.1
Income Taxes (Tables)
12 Months Ended
Jan. 26, 2025
Income Tax Disclosure [Abstract]  
Schedule of Income Tax Expense (benefit)
The income tax expense (benefit) applicable to income before income taxes consists of the following:
 Year Ended
 Jan 26, 2025Jan 28, 2024Jan 29, 2023
 (In millions)
Current income taxes:   
Federal$14,032 $5,710 $1,703 
State892 335 46 
Foreign699 502 228 
Total current15,623 6,547 1,977 
Deferred income taxes:
Federal(4,515)(2,499)(2,165)
State(242)(206)— 
Foreign280 216 
Total deferred(4,477)(2,489)(2,164)
Income tax expense (benefit)$11,146 $4,058 $(187)
Schedule of Income Before Income Tax
Income before income tax consists of the following:
 Year Ended
 Jan 26, 2025Jan 28, 2024Jan 29, 2023
 (In millions)
U.S.$77,456 $29,495 $3,477 
Foreign6,570 4,323 704 
Income before income tax$84,026 $33,818 $4,181 
Schedule of Effective Income Tax Rate Reconciliation
The income tax expense (benefit) differs from the amount computed by applying the U.S. federal statutory rate of 21% to income before income taxes as follows:
 Year Ended
 Jan 26, 2025Jan 28, 2024Jan 29, 2023
 (In millions, except percentages)
Tax expense computed at federal statutory rate$17,645 21.0 %$7,102 21.0 %$878 21.0 %
Expense (benefit) resulting from:
State income taxes, net of federal tax effect554 0.7 %120 0.4 %50 1.2 %
Foreign-derived intangible income(2,976)(3.5)%(1,408)(4.2)%(739)(17.7)%
Stock-based compensation(2,097)(2.5)%(741)(2.2)%(309)(7.4)%
U.S. federal research and development tax credit(990)(1.2)%(431)(1.3)%(278)(6.6)%
Foreign tax rate differential(984)(1.2)%(467)(1.4)%(83)(2.0)%
Acquisition termination cost— — %— — %261 6.2 %
Other(6)— %(117)(0.3)%33 0.8 %
Income tax expense (benefit)$11,146 13.3 %$4,058 12.0 %$(187)(4.5)%
Schedule of Deferred Tax Assets and Liabilities
The tax effect of temporary differences that gives rise to significant portions of the deferred tax assets and liabilities are presented below:
 Jan 26, 2025Jan 28, 2024
 (In millions)
Deferred tax assets: 
Capitalized research and development expenditure$6,256 $3,376 
GILTI deferred tax assets2,820 1,576 
Accruals and reserves, not currently deductible for tax purposes2,058 1,121 
Research and other tax credit carryforwards759 936 
Net operating loss and capital loss carryforwards456 439 
Operating lease liabilities299 263 
Stock-based compensation124 106 
Property, equipment and intangible assets82 64 
Other deferred tax assets360 179 
Gross deferred tax assets13,214 8,060 
Less valuation allowance(1,610)(1,552)
Total deferred tax assets11,604 6,508 
Deferred tax liabilities:
Unremitted earnings of foreign subsidiaries(891)(502)
Operating lease assets(286)(255)
Equity investments(264)(60)
Acquired intangibles(70)(74)
Gross deferred tax liabilities(1,511)(891)
Net deferred tax asset (1)$10,093 $5,617 
(1)    Net deferred tax asset includes long-term deferred tax assets of $11 billion and $6.1 billion and long-term deferred tax liabilities of $886 million and $462 million for fiscal years 2025 and 2024, respectively. Long-term deferred tax liabilities are included in other long-term liabilities on our Consolidated Balance Sheets.
Schedule of Gross Unrecognized Tax Benefits
A reconciliation of gross unrecognized tax benefits is as follows:
 Jan 26, 2025Jan 28, 2024Jan 29, 2023
 (In millions)
Balance at beginning of period$1,670 $1,238 $1,013 
Increases in tax positions for current year1,268 616 268 
Increases in tax positions for prior years48 87 
Decreases in tax positions for prior years(88)(148)(15)
Lapse in statute of limitations(27)(19)(20)
Settlements(10)(104)(9)
Balance at end of period$2,861 $1,670 $1,238 
v3.25.0.1
Segment Information (Tables)
12 Months Ended
Jan. 26, 2025
Segment Reporting [Abstract]  
Schedule of Reportable Segments The table below presents details of our reportable segments and the “All Other” category.
 Compute & NetworkingGraphicsAll OtherConsolidated
(In millions)
Year Ended Jan 26, 2025
   
Revenue$116,193 $14,304 $— $130,497 
Other segment items (1)33,318 9,219 
Operating income (loss)$82,875 $5,085 $(6,507)$81,453 
Year Ended Jan 28, 2024
   
Revenue$47,405 $13,517 $— $60,922 
Other segment items (1)15,389 7,671 
Operating income (loss)$32,016 $5,846 $(4,890)$32,972 
Year Ended Jan 29, 2023
   
Revenue$15,068 $11,906 $— $26,974 
Other segment items (1)9,985 7,354 
Operating income (loss)$5,083 $4,552 $(5,411)$4,224 
(1)Other segment items for the Compute & Networking and Graphics reportable segments primarily include product costs and inventory provisions, compensation and benefits excluding stock-based compensation expense, compute and infrastructure expenses, and engineering development costs.
Depreciation and amortization expense attributable to our Compute and Networking segment for fiscal years 2025, 2024, and 2023 was $732 million, $457 million, and $377 million, respectively. Depreciation and amortization expense attributable to our Graphics segment for fiscal years 2025, 2024, and 2023 was $372 million, $307 million, and $315 million, respectively. Acquisition-related intangible amortization expense is not allocated to either Compute & Networking or Graphics for purposes of making operating decisions or assessing financial performance and is included in “All Other”.
Year Ended
Jan 26, 2025Jan 28, 2024Jan 29, 2023
Reconciling items included in "All Other" category:(In millions)
Stock-based compensation expense$(4,737)$(3,549)$(2,710)
Unallocated cost of revenue and operating expenses(1,171)(728)(595)
Acquisition-related and other costs(602)(583)(674)
Acquisition termination cost— — (1,353)
Other(30)(79)
Total$(6,507)$(4,890)$(5,411)
Schedule of Revenue by Geographic Regions
Revenue by geographic area is based upon the billing location of the customer. The end customer and shipping location may be different from our customer’s billing location.
 Year Ended
 Jan 26, 2025Jan 28, 2024Jan 29, 2023
Geographic Revenue based upon Customer Billing Location:(In millions)
United States$61,257 $26,966 $8,292 
Singapore (1)23,684 6,831 2,288 
Taiwan20,573 13,405 6,986 
China (including Hong Kong)17,108 10,306 5,785 
Other7,875 3,414 3,623 
Total revenue$130,497 $60,922 $26,974 
(1) Singapore represented 18% of fiscal year 2025 total revenue based upon customer billing location. Customers use Singapore to centralize invoicing while our products are almost always shipped elsewhere. Shipments to Singapore were less than 2% of fiscal year 2025 total revenue.
Schedule of Revenue by Customer and by Specialized Markets
Sales to direct customers which represented 10% or more of total revenue, all of which were primarily attributable to the Compute & Networking segment, are presented in the following table:
Year Ended
Jan 26, 2025Jan 28, 2024
Direct Customer A12 %*
Direct Customer B11 %13 %
Direct Customer C11 %*
* Less than 10% of total revenue.
No customer represented 10% or more of total revenue for fiscal year 2023.
The following table summarizes revenue by specialized markets:
 Year Ended
 Jan 26, 2025Jan 28, 2024Jan 29, 2023
Revenue by End Market:(In millions)
Data Center$115,186 $47,525 $15,005 
Compute102,196 38,950 11,317 
Networking12,990 8,575 3,688 
Gaming11,350 10,447 9,067 
Professional Visualization1,878 1,553 1,544 
Automotive1,694 1,091 903 
OEM and Other389 306 455 
Total revenue$130,497 $60,922 $26,974 
Schedule of Long-Lived Assets by Geographic Region
The following table presents summarized information for long-lived assets by country. Long-lived assets consist of property and equipment and exclude other assets, operating lease assets, goodwill, and intangible assets.
 Jan 26, 2025Jan 28, 2024
Long-lived assets:(In millions)
United States$3,626 $2,595 
Taiwan1,481 773 
Israel840 325 
Other336 221 
Total long-lived assets$6,283 $3,914 
v3.25.0.1
Leases (Tables)
12 Months Ended
Jan. 26, 2025
Leases [Abstract]  
Schedule of Future Minimum Lease Payments
Future minimum lease obligations under our non-cancelable lease agreements as of January 26, 2025 were as follows:
Operating Lease Obligations
 (In millions)
Fiscal Year: 
2026$354 
2027331 
2028337 
2029301 
2030226 
2031 and thereafter537 
Total2,086 
Less imputed interest279 
Present value of net future minimum lease payments1,807 
Less short-term operating lease liabilities288 
Long-term operating lease liabilities$1,519 
Schedule of Other Information Related to Leases
Other information related to leases was as follows:
Year Ended
Jan 26, 2025Jan 28, 2024Jan 29, 2023
 (In millions)
Supplemental cash flows information 
Operating cash flow used for operating leases$313 $286 $184 
Operating lease assets obtained in exchange for lease obligations$877 $531 $358 
v3.25.0.1
Organization and Summary of Significant Accounting Policies (Details) - USD ($)
$ / shares in Units, $ in Millions
12 Months Ended
Jan. 26, 2025
Jan. 28, 2024
Jan. 29, 2023
Property, Plant and Equipment [Line Items]      
Cost of revenue benefit $ (32,639) $ (16,621) $ (11,618)
Operating expense benefit (16,405) (11,329) (11,132)
Net income $ 72,880 $ 29,760 $ 4,368
Basic (in USD per share) $ 2.97 $ 1.21 $ 0.18
Diluted (in USD per share) $ 2.94 $ 1.19 $ 0.17
Operating income (loss) $ 81,453 $ 32,972 $ 4,224
Valuation allowance $ 1,600 $ 1,600  
Buildings      
Property, Plant and Equipment [Line Items]      
Property, plant & equipment, useful life 30 years    
Capital Loss Carryforward      
Property, Plant and Equipment [Line Items]      
Valuation allowance $ 1,600    
Minimum      
Property, Plant and Equipment [Line Items]      
Property, plant & equipment, useful life 2 years    
Warranty liability, term 1 year    
Intangible assets, useful life 1 year    
Maximum      
Property, Plant and Equipment [Line Items]      
Property, plant & equipment, useful life 7 years    
Warranty liability, term 3 years    
Intangible assets, useful life 20 years    
v3.25.0.1
Business Combination (Details)
$ in Billions
12 Months Ended
Jan. 29, 2023
USD ($)
Arm Limited  
Business Acquisition [Line Items]  
Acquisition termination costs $ 1.4
v3.25.0.1
Stock-Based Compensation - Schedule of Stock-Based Compensation Expense (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 26, 2025
Jan. 28, 2024
Jan. 29, 2023
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Stock-based compensation expense $ 4,737 $ 3,549 $ 2,710
Cost of revenue      
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Stock-based compensation expense 178 141 138
Research and development      
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Stock-based compensation expense 3,423 2,532 1,892
Sales, general and administrative      
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Stock-based compensation expense $ 1,136 $ 876 $ 680
v3.25.0.1
Stock-Based Compensation - Summary of Equity Awards (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
12 Months Ended
Jan. 26, 2025
Jan. 28, 2024
Jan. 29, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Awards granted (in shares) 89    
Weighted average grant date fair value (in dollars per share) $ 87.99    
Summary of unearned SBC expense      
Unearned stock-based compensation expense $ 11,600    
RSUs, PSUs and Market-based PSUs      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Awards granted (in shares) 89 140 250
Estimated total grant-date fair value $ 7,834 $ 5,316 $ 4,505
Weighted average grant date fair value (in dollars per share) $ 87.99 $ 37.41 $ 18.37
Summary of unearned SBC expense      
Estimated weighted average amortization period 2 years 2 months 12 days    
Employee Stock Purchase Plan      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Awards granted (in shares) 30 30 30
Weighted average price (in dollars per share) $ 17.74 $ 15.81 $ 12.25
Weighted average grant date fair value (in dollars per share) $ 8.61 $ 6.99 $ 5.19
Summary of unearned SBC expense      
Estimated weighted average amortization period 1 year    
Fair Value Assumptions      
Risk free interest rate, minimum 3.60% 3.90% 0.00%
Risk free interest rate, maximum 5.40% 5.50% 4.60%
Volatility rate, minimum 31.00% 31.00% 43.00%
Volatility rate, maximum 75.00% 67.00% 72.00%
Dividend yield 0.03% 0.06% 0.09%
Employee Stock Purchase Plan | Minimum      
Fair Value Assumptions      
Weighted average expected life (in years) 1 month 6 days 1 month 6 days 1 month 6 days
Employee Stock Purchase Plan | Maximum      
Fair Value Assumptions      
Weighted average expected life (in years) 2 years 2 years 2 years
v3.25.0.1
Stock-Based Compensation - Narrative (Details)
shares in Millions, $ in Billions
12 Months Ended
Jan. 26, 2025
USD ($)
period
shares
Jan. 28, 2024
USD ($)
shares
Jan. 29, 2023
USD ($)
Mar. 31, 2025
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Unearned stock-based compensation expense | $ $ 11.6      
Number of shares may be issued under the Restated 2007 Plan (in shares) 274      
Number of shares available for grant (in shares) 1,400 1,500    
Employee stock purchase plan, offering period duration 24 months      
Employee stock purchase plan, number of purchase periods in offering period | period 4      
Employee stock purchase plan, purchase period duration 6 months      
RSUs, PSUs and Market-based PSUs        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Estimated weighted average amortization period 2 years 2 months 12 days      
Number of shares available for grant (in shares) 1,400      
Total fair value of units as of respective vesting dates | $ $ 15.1 $ 8.2 $ 4.3  
Performance Stock Units        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Award vesting period 4 years      
Market-based PSUs        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Award vesting period 3 years      
Employee Stock Purchase Plan        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Estimated weighted average amortization period 1 year      
Maximum employee subscription rate (as percent) 15.00%      
Purchase price of ESPP (as percent) 85.00%      
Shares reserved for future issuance (in shares) 2,200      
Employee Stock Purchase Plan | Forecast        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Maximum employee subscription rate (as percent)       25.00%
v3.25.0.1
Stock-Based Compensation - Equity Incentive Plans (Details)
shares in Millions
12 Months Ended
Jan. 26, 2025
$ / shares
shares
Number of Shares  
Beginning balance (in shares) | shares 367
Granted (in shares) | shares 89
Vested (in shares) | shares (173)
Canceled and forfeited (in shares) | shares (9)
Ending balance (in shares) | shares 274
Vested and expected to vest (in shares) | shares 272
Weighted Average Grant-Date Fair Value Per Share  
Beginning balance (in USD per share) | $ / shares $ 24.59
Granted (in USD per share) | $ / shares 87.99
Vested (in USD per share) | $ / shares 24.89
Canceled and forfeited (in USD per share) | $ / shares 32.10
Ending balance (in USD per share) | $ / shares 44.75
Vested and expected to vest (in USD per share) | $ / shares $ 44.59
v3.25.0.1
Net Income Per Share (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
12 Months Ended
Jan. 26, 2025
Jan. 28, 2024
Jan. 29, 2023
Numerator:      
Net income $ 72,880 $ 29,760 $ 4,368
Denominator:      
Basic weighted average shares (in shares) 24,555 24,690 24,870
Dilutive impact of outstanding equity awards (in shares) 249 250 200
Diluted weighted average shares (in shares) 24,804 24,940 25,070
Net income per share:      
Basic (in USD per share) $ 2.97 $ 1.21 $ 0.18
Diluted (in USD per share) $ 2.94 $ 1.19 $ 0.17
Anti-dilutive awards excluded from diluted net income per share (in shares) 51 150 400
v3.25.0.1
Goodwill (Details) - USD ($)
12 Months Ended
Jan. 26, 2025
Jan. 28, 2024
Jan. 29, 2023
Goodwill [Line Items]      
Goodwill $ 5,188,000,000 $ 4,430,000,000  
Goodwill acquired during period 758,000,000    
Goodwill impairment loss 0 0 $ 0
Compute & Networking      
Goodwill [Line Items]      
Goodwill 4,800,000,000 4,100,000,000  
Graphics      
Goodwill [Line Items]      
Goodwill $ 370,000,000 $ 370,000,000  
v3.25.0.1
Amortizable Intangible Assets (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 26, 2025
Jan. 28, 2024
Jan. 29, 2023
Finite-Lived Intangible Assets [Line Items]      
Gross Carrying Amount $ 3,349 $ 3,091  
Accumulated Amortization (2,542) (1,979)  
Net  Carrying Amount 807 1,112  
Amortization expense 593 614 $ 699
Future amortization expense associated with intangible assets      
2026 354    
2027 236    
2028 84    
2029 31    
2030 10    
2031 and thereafter 92    
Net  Carrying Amount 807 1,112  
Acquisition-related intangible assets      
Finite-Lived Intangible Assets [Line Items]      
Gross Carrying Amount 2,900 2,642  
Accumulated Amortization (2,264) (1,720)  
Net  Carrying Amount 636 922  
Future amortization expense associated with intangible assets      
Net  Carrying Amount 636 922  
Patents and licensed technology      
Finite-Lived Intangible Assets [Line Items]      
Gross Carrying Amount 449 449  
Accumulated Amortization (278) (259)  
Net  Carrying Amount 171 190  
Future amortization expense associated with intangible assets      
Net  Carrying Amount $ 171 $ 190  
v3.25.0.1
Cash Equivalents and Marketable Securities - Cash Equivalents and Marketable Securities (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 26, 2025
Jan. 28, 2024
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost $ 42,062 $ 25,684
Unrealized Gain 100 56
Unrealized Loss (56) (16)
Estimated Fair Value 42,106 25,724
Cash Equivalents 7,866 7,020
Marketable Securities   18,704
Estimated fair Value, Total 42,487  
Marketable Securities, Total 34,621  
Level 1    
Debt Securities, Available-for-sale [Line Items]    
Publicly-held equity securities 0 225
Corporate debt securities    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost 18,504 10,126
Unrealized Gain 51 31
Unrealized Loss (29) (5)
Estimated Fair Value 18,526 10,152
Cash Equivalents 2,071 2,231
Marketable Securities 16,455 7,921
Debt securities issued by the U.S. Treasury    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost 16,749 9,517
Unrealized Gain 42 17
Unrealized Loss (22) (10)
Estimated Fair Value 16,769 9,524
Cash Equivalents 1,801 1,315
Marketable Securities 14,968 8,209
Money market funds    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost 3,760 3,031
Unrealized Gain 0 0
Unrealized Loss 0 0
Estimated Fair Value 3,760 3,031
Cash Equivalents 3,760 3,031
Marketable Securities 0 0
Debt securities issued by U.S. government agencies    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost 2,775 2,326
Unrealized Gain 7 8
Unrealized Loss (5) (1)
Estimated Fair Value 2,777 2,333
Cash Equivalents 0 89
Marketable Securities 2,777 2,244
Foreign government bonds    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost 177 174
Unrealized Gain 0 0
Unrealized Loss 0 0
Estimated Fair Value 177 174
Cash Equivalents 137 60
Marketable Securities 40 114
Certificates of deposit    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost 97 510
Unrealized Gain 0 0
Unrealized Loss 0 0
Estimated Fair Value 97 510
Cash Equivalents 97 294
Marketable Securities 0 $ 216
Total debt securities with fair value adjustments recorded in other comprehensive income    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost 42,062  
Unrealized Gain 100  
Unrealized Loss (56)  
Estimated Fair Value 42,106  
Cash Equivalents 7,866  
Marketable Securities 34,240  
Publicly-held equity securities    
Debt Securities, Available-for-sale [Line Items]    
Publicly-held equity securities 381  
Net unrealized gains on investments 163  
Net realized gain on equity securities $ 88  
v3.25.0.1
Cash Equivalents and Marketable Securities - Unrealized Losses Aggregated by Investment Category (Details) - USD ($)
$ in Millions
Jan. 26, 2025
Jan. 28, 2024
Estimated Fair Value    
Less than 12 Months $ 12,422 $ 5,319
12 Months or Greater 213 1,696
Total 12,635 7,015
Gross Unrealized Loss    
Less than 12 Months (56) (9)
12 Months or Greater 0 (7)
Total (56) (16)
Debt securities issued by the U.S. Treasury    
Estimated Fair Value    
Less than 12 Months 6,315 3,343
12 Months or Greater 177 1,078
Total 6,492 4,421
Gross Unrealized Loss    
Less than 12 Months (22) (5)
12 Months or Greater 0 (5)
Total (22) (10)
Corporate debt securities    
Estimated Fair Value    
Less than 12 Months 5,291 1,306
12 Months or Greater 15 618
Total 5,306 1,924
Gross Unrealized Loss    
Less than 12 Months (29) (3)
12 Months or Greater 0 (2)
Total (29) (5)
Debt securities issued by U.S. government agencies    
Estimated Fair Value    
Less than 12 Months 816 670
12 Months or Greater 21 0
Total 837 670
Gross Unrealized Loss    
Less than 12 Months (5) (1)
12 Months or Greater 0 0
Total $ (5) $ (1)
v3.25.0.1
Cash Equivalents and Marketable Securities - Amortized Cost and Estimated Fair Value of Cash Equivalents and Marketable Securities (Details) - USD ($)
$ in Millions
Jan. 26, 2025
Jan. 28, 2024
Amortized Cost    
Less than one year $ 18,426 $ 16,336
Due in 1 - 5 years 23,636 9,348
Amortized Cost 42,062 25,684
Estimated Fair Value    
Less than one year 18,450 16,329
Due in 1 - 5 years 23,656 9,395
Estimated Fair Value $ 42,106 $ 25,724
v3.25.0.1
Fair Value of Financial Assets and Liabilities and Non-marketable Equity Securities (Details) - USD ($)
$ in Millions
Jan. 26, 2025
Jan. 28, 2024
Assets    
Cash equivalents and marketable securities $ 42,106 $ 25,724
0.584% Notes Due 2024    
Financial assets and liabilities measured at fair value    
Interest rate (as percent) 0.584%  
3.20% Notes Due 2026    
Financial assets and liabilities measured at fair value    
Interest rate (as percent) 3.20%  
1.55% Notes Due 2028    
Financial assets and liabilities measured at fair value    
Interest rate (as percent) 1.55%  
2.85% Notes Due 2030    
Financial assets and liabilities measured at fair value    
Interest rate (as percent) 2.85%  
2.00% Notes Due 2031    
Financial assets and liabilities measured at fair value    
Interest rate (as percent) 2.00%  
3.50% Notes Due 2040    
Financial assets and liabilities measured at fair value    
Interest rate (as percent) 3.50%  
3.50% Notes Due 2050    
Financial assets and liabilities measured at fair value    
Interest rate (as percent) 3.50%  
3.70% Notes Due 2060    
Financial assets and liabilities measured at fair value    
Interest rate (as percent) 3.70%  
Level 1    
Assets    
Publicly-held equity securities $ 0 225
Level 1 | Money market funds    
Assets    
Cash equivalents and marketable securities 3,760 3,031
Level 1 | Publicly-held equity securities    
Assets    
Cash equivalents and marketable securities 381 0
Level 2 | 0.584% Notes Due 2024    
Liabilities    
Liabilities 0 1,228
Level 2 | 3.20% Notes Due 2026    
Liabilities    
Liabilities 982 970
Level 2 | 1.55% Notes Due 2028    
Liabilities    
Liabilities 1,136 1,115
Level 2 | 2.85% Notes Due 2030    
Liabilities    
Liabilities 1,376 1,367
Level 2 | 2.00% Notes Due 2031    
Liabilities    
Liabilities 1,064 1,057
Level 2 | 3.50% Notes Due 2040    
Liabilities    
Liabilities 824 851
Level 2 | 3.50% Notes Due 2050    
Liabilities    
Liabilities 1,482 1,604
Level 2 | 3.70% Notes Due 2060    
Liabilities    
Liabilities 367 403
Level 2 | Corporate debt securities    
Assets    
Cash equivalents and marketable securities 18,526 10,152
Level 2 | Debt securities issued by the U.S. Treasury    
Assets    
Cash equivalents and marketable securities 16,769 9,524
Level 2 | Debt securities issued by U.S. government agencies    
Assets    
Cash equivalents and marketable securities 2,777 2,333
Level 2 | Foreign government bonds    
Assets    
Cash equivalents and marketable securities 177 174
Level 2 | Certificates of deposit    
Assets    
Cash equivalents and marketable securities $ 97 $ 510
v3.25.0.1
Fair Value of Financial Assets and Liabilities and Non-marketable Equity Securities - Carrying Value of Non-marketable Equity Securities (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 26, 2025
Jan. 28, 2024
Investments, Debt and Equity Securities [Abstract]    
Carrying amount, beginning $ 1,321 $ 288
Net additions 1,309 859
Unrealized gains 816 194
Impairments and unrealized losses (59) (20)
Carrying amount, ending $ 3,387 $ 1,321
v3.25.0.1
Fair Value of Financial Assets and Liabilities and Non-marketable Equity Securities - Cumulative Gross (Details) - USD ($)
$ in Millions
3 Months Ended
Jan. 26, 2025
Jan. 28, 2024
Other Investment Not Readily Marketable [Line Items]    
Cumulative gross unrealized gains $ 1,100 $ 270
Cumulative gross losses and impairments 105 $ 45
A Private Company Investment    
Other Investment Not Readily Marketable [Line Items]    
Unrealized gain on secondary equity transaction $ 565  
v3.25.0.1
Balance Sheet Components - Narrative (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 26, 2025
Jan. 28, 2024
Jan. 29, 2023
Property, Plant and Equipment [Line Items]      
Depreciation expense $ 1,300 $ 894 $ 844
Accumulated amortization of lease hold improvements and finance leases 410 400  
Capital expenditures incurred but not yet paid $ 525 $ 170 $ 374
Customer one | Accounts Receivable | Customer Concentration Risk      
Property, Plant and Equipment [Line Items]      
Concentration risk (as percent) 17.00% 24.00%  
Customer two | Accounts Receivable | Customer Concentration Risk      
Property, Plant and Equipment [Line Items]      
Concentration risk (as percent) 16.00% 11.00%  
v3.25.0.1
Balance Sheet Components - Inventories (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 26, 2025
Jan. 28, 2024
Inventories    
Raw materials $ 3,408 $ 1,719
Work in process 3,399 1,505
Finished goods 3,273 2,058
Total inventories (1) 10,080 5,282
Inventory reserves expenses $ 1,600 $ 774
v3.25.0.1
Balance Sheet Components - Property and Equipment (Details) - USD ($)
$ in Millions
Jan. 26, 2025
Jan. 28, 2024
Property, Plant and Equipment [Line Items]    
Total property and equipment, gross $ 10,684 $ 7,423
Accumulated depreciation and amortization (4,401) (3,509)
Total property and equipment, net $ 6,283 3,914
Minimum    
Property, Plant and Equipment [Line Items]    
Property, plant & equipment, useful life 2 years  
Maximum    
Property, Plant and Equipment [Line Items]    
Property, plant & equipment, useful life 7 years  
Land    
Property, Plant and Equipment [Line Items]    
Total property and equipment, gross $ 511 218
Buildings, leasehold improvements, and furniture    
Property, Plant and Equipment [Line Items]    
Total property and equipment, gross 2,076 1,816
Equipment, compute hardware, and software    
Property, Plant and Equipment [Line Items]    
Total property and equipment, gross $ 7,568 5,200
Equipment, compute hardware, and software | Minimum    
Property, Plant and Equipment [Line Items]    
Property, plant & equipment, useful life 2 years  
Equipment, compute hardware, and software | Maximum    
Property, Plant and Equipment [Line Items]    
Property, plant & equipment, useful life 7 years  
Construction in process    
Property, Plant and Equipment [Line Items]    
Total property and equipment, gross $ 529 $ 189
Buildings    
Property, Plant and Equipment [Line Items]    
Property, plant & equipment, useful life 30 years  
v3.25.0.1
Balance Sheet Components - Other Assets (Details) - USD ($)
$ in Millions
Jan. 26, 2025
Jan. 28, 2024
Supply Commitment [Line Items]    
Non-marketable equity securities $ 3,387 $ 1,321
Prepaid supply and capacity agreements 1,747 2,458
Income tax receivable 750 0
Prepaid royalties 340 364
Other 201 357
Other assets 6,425 4,500
Prepaid expenses and other current assets 3,771 3,080
Supply and Capacity Agreements    
Supply Commitment [Line Items]    
Prepaid expenses and other current assets $ 3,300 $ 2,500
v3.25.0.1
Balance Sheet Components - Accrued and Other Current Liabilities (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 26, 2025
Jan. 28, 2024
Jan. 29, 2023
Accruals [Line Items]      
Customer program accruals $ 4,880 $ 2,081  
Excess inventory purchase obligations 2,095 1,655  
Product warranty and return provisions 1,373 415  
Taxes payable 881 296  
Accrued payroll and related expenses 848 675  
Deferred revenue 837 764  
Operating leases 288 228  
Licenses and royalties 175 182  
Unsettled share repurchases 132 187  
Other 228 199  
Total accrued and other current liabilities $ 11,737 $ 6,682  
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List] Total accrued and other current liabilities Total accrued and other current liabilities  
Cost of revenue $ 32,639 $ 16,621 $ 11,618
Inventory purchase obligations in excess of projections      
Accruals [Line Items]      
Cost of revenue 2,000 1,400  
Customer advances and unearned revenue      
Accruals [Line Items]      
Deferred revenue $ 81 $ 233  
v3.25.0.1
Balance Sheet Components - Other Long-Term Liabilities (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 26, 2025
Jan. 28, 2024
Other Long-Term Liabilities:    
Income tax payable $ 2,188 $ 1,361
Deferred revenue 976 573
Deferred income tax 886 462
Licenses payable 116 80
Other 79 65
Total other long-term liabilities 4,245 2,541
Customer advances included in deferred revenue 3,600 783
Customer advances included in revenue recognized $ 3,700 $ 585
v3.25.0.1
Balance Sheet Components - Deferred Revenue (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 26, 2025
Jan. 28, 2024
Movement in Deferred Revenue [Roll Forward]    
Balance at beginning of period $ 1,337 $ 572
Deferred revenue additions (1) 5,083 2,038
Revenue recognized (2) (4,607) (1,273)
Balance at end of period $ 1,813 $ 1,337
v3.25.0.1
Balance Sheet Components - Revenue Remaining Performance Obligation (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 26, 2025
Jan. 28, 2024
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]    
Deferred revenue $ 729 $ 338
Remaining performance obligation 1,700  
Remaining performance obligations from deferred revenue 1,600  
Remaining performance obligations not yet billed nor recognized as revenue $ 151  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-27    
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]    
Remaining performance obligation (as percent) 39.00%  
Expected performance period 12 months  
v3.25.0.1
Derivative Financial Instruments - Notional Value of Our Foreign Currency Forward Contracts Outstanding (Details) - Foreign currency forward contract - USD ($)
$ in Millions
Jan. 26, 2025
Jan. 28, 2024
Designated as accounting hedges    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Notional values of derivative contracts $ 1,424 $ 1,168
Not designated as accounting hedges    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Notional values of derivative contracts $ 1,297 $ 597
v3.25.0.1
Derivative Financial Instruments - Narrative (Details)
12 Months Ended
Jan. 26, 2025
Foreign currency forward contract  
Derivative [Line Items]  
Maximum maturity period 18 months
v3.25.0.1
Debt - Narrative (Details) - USD ($)
12 Months Ended
Jan. 26, 2025
Jan. 28, 2024
Jan. 29, 2023
Debt Instrument [Line Items]      
Repayment of debt $ 1,250,000,000 $ 1,250,000,000 $ 0
Outstanding commercial paper 0    
Commercial Paper      
Debt Instrument [Line Items]      
Maximum borrowing capacity $ 575,000,000    
v3.25.0.1
Debt - Schedule of Debt (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 26, 2025
Jan. 28, 2024
Debt Instrument [Line Items]    
Unamortized debt discount and issuance costs $ (37) $ (41)
Net carrying amount 8,463 9,709
Less short-term portion 0 (1,250)
Long-term debt $ 8,463 8,459
0.584% Notes Due 2024    
Debt Instrument [Line Items]    
Interest rate (as percent) 0.584%  
Effective Interest Rate (as percent) 0.66%  
Gross carrying amount $ 0 1,250
3.20% Notes Due 2026    
Debt Instrument [Line Items]    
Interest rate (as percent) 3.20%  
Expected Remaining Term (years) 1 year 7 months 6 days  
Effective Interest Rate (as percent) 3.31%  
Gross carrying amount $ 1,000 1,000
1.55% Notes Due 2028    
Debt Instrument [Line Items]    
Interest rate (as percent) 1.55%  
Expected Remaining Term (years) 3 years 4 months 24 days  
Effective Interest Rate (as percent) 1.64%  
Gross carrying amount $ 1,250 1,250
2.85% Notes Due 2030    
Debt Instrument [Line Items]    
Interest rate (as percent) 2.85%  
Expected Remaining Term (years) 5 years 2 months 12 days  
Effective Interest Rate (as percent) 2.93%  
Gross carrying amount $ 1,500 1,500
2.00% Notes Due 2031    
Debt Instrument [Line Items]    
Interest rate (as percent) 2.00%  
Expected Remaining Term (years) 6 years 4 months 24 days  
Effective Interest Rate (as percent) 2.09%  
Gross carrying amount $ 1,250 1,250
3.50% Notes Due 2040    
Debt Instrument [Line Items]    
Interest rate (as percent) 3.50%  
Expected Remaining Term (years) 15 years 2 months 12 days  
Effective Interest Rate (as percent) 3.54%  
Gross carrying amount $ 1,000 1,000
3.50% Notes Due 2050    
Debt Instrument [Line Items]    
Interest rate (as percent) 3.50%  
Expected Remaining Term (years) 25 years 2 months 12 days  
Effective Interest Rate (as percent) 3.54%  
Gross carrying amount $ 2,000 2,000
3.70% Notes Due 2060    
Debt Instrument [Line Items]    
Interest rate (as percent) 3.70%  
Expected Remaining Term (years) 35 years 2 months 12 days  
Effective Interest Rate (as percent) 3.73%  
Gross carrying amount $ 500 $ 500
v3.25.0.1
Commitments and Contingencies - Narrative (Details) - USD ($)
$ in Millions
Feb. 05, 2025
Jan. 26, 2025
Jan. 28, 2024
Jan. 29, 2023
Jan. 30, 2022
Supply Commitment [Line Items]          
Inventory purchase and long-term supply agreements   $ 30,800      
Other purchase obligations   14,300      
Warranty accrual   1,290 $ 306 $ 82 $ 46
Securities Class Action and Derivative Lawsuits | Subsequent Event          
Supply Commitment [Line Items]          
Motion to extend stay 30 days        
License and Service          
Supply Commitment [Line Items]          
Other purchase obligations   $ 10,900      
v3.25.0.1
Commitments and Contingencies - Summary of Future Commitments Due by Year (Details)
$ in Millions
Jan. 26, 2025
USD ($)
Fiscal Year:  
2026 $ 35,727
2027 3,666
2028 2,992
2029 2,054
2030 422
2031 and thereafter 218
Total $ 45,079
v3.25.0.1
Commitments and Contingencies - Schedule of Product Warranty Liabilities (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 26, 2025
Jan. 28, 2024
Jan. 29, 2023
Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward]      
Beginning Balance $ 306 $ 82 $ 46
Additions 1,203 278 145
Utilization (219) (54) (109)
Ending Balance $ 1,290 $ 306 $ 82
v3.25.0.1
Income Taxes - Components of Income Tax Expense (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 26, 2025
Jan. 28, 2024
Jan. 29, 2023
Current income taxes:      
Federal $ 14,032 $ 5,710 $ 1,703
State 892 335 46
Foreign 699 502 228
Total current 15,623 6,547 1,977
Deferred income taxes:      
Federal (4,515) (2,499) (2,165)
State (242) (206) 0
Foreign 280 216 1
Total deferred (4,477) (2,489) (2,164)
Income tax expense (benefit) 11,146 4,058 (187)
Income before Income Taxes      
U.S. 77,456 29,495 3,477
Foreign 6,570 4,323 704
Income before income tax $ 84,026 $ 33,818 $ 4,181
v3.25.0.1
Income Taxes - Income Tax Reconciliation (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 26, 2025
Jan. 28, 2024
Jan. 29, 2023
Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract]      
Tax expense computed at federal statutory rate $ 17,645 $ 7,102 $ 878
State income taxes, net of federal tax effect 554 120 50
Foreign-derived intangible income (2,976) (1,408) (739)
Stock-based compensation (2,097) (741) (309)
U.S. federal research and development tax credit (990) (431) (278)
Foreign tax rate differential (984) (467) (83)
Acquisition termination cost 0 0 261
Other (6) (117) 33
Income tax expense (benefit) $ 11,146 $ 4,058 $ (187)
Effective Income Tax Rate Reconciliation, Percent [Abstract]      
Tax expense computed at federal statutory rate 21.00% 21.00% 21.00%
State income taxes, net of federal tax effect 0.70% 0.40% 1.20%
Foreign-derived intangible income (3.50%) (4.20%) (17.70%)
Stock-based compensation (2.50%) (2.20%) (7.40%)
U.S. federal research and development tax credit (1.20%) (1.30%) (6.60%)
Foreign tax rate differential (1.20%) (1.40%) (2.00%)
Acquisition termination cost 0 0 0.062
Other 0.00% (0.30%) 0.80%
Effective tax rate (as percent) 13.30% 12.00% (4.50%)
v3.25.0.1
Income Taxes - Deferred Taxes (Details) - USD ($)
$ in Millions
Jan. 26, 2025
Jan. 28, 2024
Deferred tax assets:    
Capitalized research and development expenditure $ 6,256 $ 3,376
GILTI deferred tax assets 2,820 1,576
Accruals and reserves, not currently deductible for tax purposes 2,058 1,121
Research and other tax credit carryforwards 759 936
Net operating loss and capital loss carryforwards 456 439
Operating lease liabilities 299 263
Stock-based compensation 124 106
Property, equipment and intangible assets 82 64
Other deferred tax assets 360 179
Gross deferred tax assets 13,214 8,060
Less valuation allowance (1,610) (1,552)
Total deferred tax assets 11,604 6,508
Deferred tax liabilities:    
Unremitted earnings of foreign subsidiaries (891) (502)
Operating lease assets (286) (255)
Equity investments (264) (60)
Acquired intangibles (70) (74)
Gross deferred tax liabilities (1,511) (891)
Net deferred tax asset 10,093 5,617
Deferred tax assets, noncurrent    
Deferred tax assets:    
Gross deferred tax assets 11,000 6,100
Other long-term liabilities    
Deferred tax liabilities:    
Gross deferred tax liabilities $ (886) $ (462)
v3.25.0.1
Income Taxes - Narrative (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 26, 2025
Jan. 28, 2024
Jan. 29, 2023
Income Tax Contingency [Line Items]      
Deferred tax assets $ 13,214 $ 8,060  
Deferred tax liabilities 1,511 891  
Undistributed earnings of foreign subsidiaries 1,400    
Valuation allowance 1,600 1,600  
Unrecognized tax benefits that would affect effective tax rate 2,000    
Interest and taxes recognized related to unrecognized tax benefits 92 42 $ 33
Interest and penalties accrued 251 140  
Capital Loss Carryforward      
Income Tax Contingency [Line Items]      
Valuation allowance 1,600    
Other long-term liabilities      
Income Tax Contingency [Line Items]      
Deferred tax liabilities 886 462  
Deferred tax assets, noncurrent      
Income Tax Contingency [Line Items]      
Deferred tax assets 11,000 $ 6,100  
Federal      
Income Tax Contingency [Line Items]      
Net operating loss carryforwards 479    
Research tax credit carryforwards 46    
Federal | Capital Loss Carryforward      
Income Tax Contingency [Line Items]      
Federal capital loss carryforwards 1,300    
Foreign Country      
Income Tax Contingency [Line Items]      
Net operating loss carryforwards 349    
State and Local Jurisdiction      
Income Tax Contingency [Line Items]      
Net operating loss carryforwards 332    
Research tax credit carryforwards 1,500    
California      
Income Tax Contingency [Line Items]      
Research tax credit carryforwards 1,400    
Other states      
Income Tax Contingency [Line Items]      
Research tax credit carryforwards $ 98    
v3.25.0.1
Income Taxes - Unrecognized Tax Benefits (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 26, 2025
Jan. 28, 2024
Jan. 29, 2023
Unrecognized Tax Benefits [Roll Forward]      
Balance at beginning of period $ 1,670 $ 1,238 $ 1,013
Increases in tax positions for current year 1,268 616 268
Increases in tax positions for prior years 48 87 1
Decreases in tax positions for prior years (88) (148) (15)
Lapse in statute of limitations (27) (19) (20)
Settlements (10) (104) (9)
Balance at end of period 2,861 $ 1,670 $ 1,238
Unrecognized tax benefits that would affect effective tax rate $ 2,000    
v3.25.0.1
Shareholders' Equity (Details) - USD ($)
shares in Millions, $ in Millions
1 Months Ended 12 Months Ended
Aug. 26, 2024
Feb. 21, 2025
Jan. 26, 2025
Jan. 28, 2024
Jan. 29, 2023
Equity, Class of Treasury Stock [Line Items]          
Additional number of shares authorized to be repurchased $ 50,000        
Number of share repurchased (in shares)     310 210  
Shares repurchased     $ 34,015 $ 9,746 $ 10,039
Stock repurchase program, authorized amount     38,700    
Dividends paid     834 395 398
Subsequent Event          
Equity, Class of Treasury Stock [Line Items]          
Number of share repurchased (in shares)   29      
Shares repurchased   $ 3,700      
Additional Paid-in Capital          
Equity, Class of Treasury Stock [Line Items]          
Shares repurchased     189 27 4
Retained Earnings          
Equity, Class of Treasury Stock [Line Items]          
Shares repurchased     $ 33,825 $ 9,719 $ 10,034
v3.25.0.1
Employee Retirement Plans (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 26, 2025
Jan. 28, 2024
Jan. 29, 2023
Retirement Benefits [Abstract]      
Defined contribution plan costs $ 314 $ 255 $ 227
v3.25.0.1
Segment Information - Narrative (Details)
$ in Millions
12 Months Ended
Jan. 26, 2025
USD ($)
segment
Jan. 28, 2024
USD ($)
Jan. 29, 2023
USD ($)
Segment Reporting Information [Line Items]      
Number of reportable segments | segment 2    
Depreciation and amortization $ 1,864 $ 1,508 $ 1,544
Compute & Networking      
Segment Reporting Information [Line Items]      
Depreciation and amortization 732 457 377
Graphics      
Segment Reporting Information [Line Items]      
Depreciation and amortization $ 372 $ 307 $ 315
Revenue | Customer Concentration Risk | Non-US      
Segment Reporting Information [Line Items]      
Concentration risk (as percent) 53.00% 56.00% 69.00%
v3.25.0.1
Segment Information - Reportable Segments (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 26, 2025
Jan. 28, 2024
Jan. 29, 2023
Segment Reporting Information [Line Items]      
Revenue $ 130,497 $ 60,922 $ 26,974
Operating income (loss) 81,453 32,972 4,224
All Other      
Segment Reporting Information [Line Items]      
Revenue 0 0 0
Operating income (loss) (6,507) (4,890) (5,411)
Compute & Networking | Operating segments      
Segment Reporting Information [Line Items]      
Revenue 116,193 47,405 15,068
Other segment items 33,318 15,389 9,985
Operating income (loss) 82,875 32,016 5,083
Graphics | Operating segments      
Segment Reporting Information [Line Items]      
Revenue 14,304 13,517 11,906
Other segment items 9,219 7,671 7,354
Operating income (loss) $ 5,085 $ 5,846 $ 4,552
v3.25.0.1
Segment Information - Reconciling Items (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 26, 2025
Jan. 28, 2024
Jan. 29, 2023
Segment Reporting Information [Line Items]      
Stock-based compensation expense $ (4,737) $ (3,549) $ (2,709)
Operating income 81,453 32,972 4,224
All Other      
Segment Reporting Information [Line Items]      
Stock-based compensation expense (4,737) (3,549) (2,710)
Unallocated cost of revenue and operating expenses (1,171) (728) (595)
Acquisition-related and other costs (602) (583) (674)
Acquisition termination cost 0 0 (1,353)
Other 3 (30) (79)
Operating income $ (6,507) $ (4,890) $ (5,411)
v3.25.0.1
Segment Information - Revenue and Long-lived Assets by Region (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 26, 2025
Jan. 28, 2024
Jan. 29, 2023
Revenues and Long-Lived Assets      
Total revenue $ 130,497 $ 60,922 $ 26,974
Total long-lived assets 6,283 3,914  
United States      
Revenues and Long-Lived Assets      
Total revenue 61,257 26,966 8,292
Total long-lived assets 3,626 2,595  
Singapore      
Revenues and Long-Lived Assets      
Total revenue 23,684 6,831 2,288
Taiwan      
Revenues and Long-Lived Assets      
Total revenue 20,573 13,405 6,986
Total long-lived assets 1,481 773  
China (including Hong Kong)      
Revenues and Long-Lived Assets      
Total revenue 17,108 10,306 5,785
Israel      
Revenues and Long-Lived Assets      
Total long-lived assets 840 325  
Other      
Revenues and Long-Lived Assets      
Total revenue 7,875 3,414 $ 3,623
Total long-lived assets $ 336 $ 221  
v3.25.0.1
Segment Information - Revenue and Accounts Receivable by Major Customer (Details) - Revenue
12 Months Ended
Jan. 26, 2025
Jan. 28, 2024
Singapore | Geographic concentration risk    
Revenue, Major Customer [Line Items]    
Concentration risk (as percent) 18.00%  
Singapore | Product concentration risk    
Revenue, Major Customer [Line Items]    
Concentration risk (as percent) 2.00%  
Direct Customer A | Customer Concentration Risk | Compute & Networking    
Revenue, Major Customer [Line Items]    
Concentration risk (as percent) 12.00%  
Direct Customer B | Customer Concentration Risk | Compute & Networking    
Revenue, Major Customer [Line Items]    
Concentration risk (as percent) 11.00% 13.00%
Direct Customer C | Customer Concentration Risk | Compute & Networking    
Revenue, Major Customer [Line Items]    
Concentration risk (as percent) 11.00%  
v3.25.0.1
Segment Information - Schedule of Revenue by Market (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 26, 2025
Jan. 28, 2024
Jan. 29, 2023
Revenue from External Customer [Line Items]      
Revenue $ 130,497 $ 60,922 $ 26,974
Data Center      
Revenue from External Customer [Line Items]      
Revenue 115,186 47,525 15,005
Compute      
Revenue from External Customer [Line Items]      
Revenue 102,196 38,950 11,317
Networking      
Revenue from External Customer [Line Items]      
Revenue 12,990 8,575 3,688
Gaming      
Revenue from External Customer [Line Items]      
Revenue 11,350 10,447 9,067
Professional Visualization      
Revenue from External Customer [Line Items]      
Revenue 1,878 1,553 1,544
Automotive      
Revenue from External Customer [Line Items]      
Revenue 1,694 1,091 903
OEM and Other      
Revenue from External Customer [Line Items]      
Revenue $ 389 $ 306 $ 455
v3.25.0.1
Leases - Schedule of Future Minimum Lease Payments (Details) - USD ($)
$ in Millions
Jan. 26, 2025
Jan. 28, 2024
Leases [Abstract]    
2026 $ 354  
2027 331  
2028 337  
2029 301  
2030 226  
2031 and thereafter 537  
Total 2,086  
Less imputed interest 279  
Present value of net future minimum lease payments $ 1,807  
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List] Accrued and other current liabilities Accrued and other current liabilities
Less short-term operating lease liabilities $ 288 $ 228
Long-term operating lease liabilities $ 1,519 $ 1,119
v3.25.0.1
Leases - Narrative (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 26, 2025
Jan. 28, 2024
Jan. 29, 2023
Lessee, Lease, Description [Line Items]      
Lease not yet commenced, undiscounted amount $ 7,600    
Operating lease expense $ 356 $ 269 $ 193
Weighted average remaining lease term - operating leases 6 years 6 months 6 years 1 month 6 days  
Weighted average discount rate - operating leases 4.16% 3.76%  
Minimum      
Lessee, Lease, Description [Line Items]      
Lease not yet commenced, term of contract 3 years    
Maximum      
Lessee, Lease, Description [Line Items]      
Lease not yet commenced, term of contract 15 years 6 months    
v3.25.0.1
Leases - Schedule of other lease information (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 26, 2025
Jan. 28, 2024
Jan. 29, 2023
Leases [Abstract]      
Operating cash flow used for operating leases $ 313 $ 286 $ 184
Operating lease assets obtained in exchange for lease obligations $ 877 $ 531 $ 358
v3.25.0.1
Schedule II - Valuation and Qualifying Accounts (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 26, 2025
Jan. 28, 2024
Jan. 29, 2023
Allowance for doubtful accounts      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at Beginning of Period $ 4 $ 4 $ 4
Additions 0 0 0
Deductions 0 0 0
Balance at End of Period 4 4 4
Sales return allowance      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at Beginning of Period 109 26 13
Additions 151 213 104
Deductions (178) (130) (91)
Balance at End of Period 82 109 26
Deferred tax valuation allowance      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at Beginning of Period 1,552 1,484 907
Additions 58 162 577
Deductions 0 (94) 0
Balance at End of Period $ 1,610 $ 1,552 $ 1,484